Establishment of Revisit User Fee Program for Medicare Survey and Certification Activities, 53628-53649 [E7-18458]
Download as PDF
53628
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
authority for the revisit user fee is
continued, we will use the current fee
schedule in this rule for the assessment
of such fees until such time as a new fee
schedule notice is proposed and
published in final form.
DATES: Effective Date: These regulations
are effective on September 19, 2007.
FOR FURTHER INFORMATION CONTACT:
Carla McGregor, (410) 786–0663
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Parts 424, 488, and 489
[CMS–2268–F]
RIN 0938–AO96
Establishment of Revisit User Fee
Program for Medicare Survey and
Certification Activities
Table of Contents
I. Background
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final rule.
jlentini on PROD1PC65 with RULES2
AGENCY:
A. Overview
SUMMARY: This final rule will establish
a system of revisit user fees applicable
to health care facilities that have been
cited for deficiencies during initial
certification, recertification, or
substantiated complaint surveys and
require a revisit to confirm that
corrections to previously-identified
deficiencies have been remedied.
Consistent with the President’s longterm goal to promote quality of health
care and to cut the deficit in half by
fiscal year (FY) 2009, the FY 2007
Department of Health and Human
Services’ (HHS) budget request included
both new mandatory savings proposals
and a requirement that user fees be
applied to health care providers that
have failed to comply with Federal
quality of care requirements. The
‘‘Revisit User Fees’’ will affect only
those providers or suppliers for which
a revisit is required to confirm that
previously-identified failures to meet
federal quality of care requirements
have been remedied. The fees are
estimated at $37.3 million annually and
will recover the costs associated with
the Medicare Survey and Certification
program’s revisit surveys. The fees will
take effect on the date of publication of
the final rule and will be in effect until
the date that the continued authority
provided by Congress expires. At the
time of publication of this regulation the
applicable date is September 30, 2007.
If no legislation is enacted, the fees are
not retroactive to the beginning of the
fiscal year. Any provider or supplier
that has a revisit survey conducted on
or after the date of publication will be
assessed a revisit user fee and will be
notified of the assessment upon data
system reconciliation which can occur
following the closing of the fiscal year.
The fees will be available to CMS until
expended. The revisit user fee is
included in the President’s proposed FY
2008 budget. We note through the
publication of this final rule that if
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
In the June 29, 2007 Federal Register
(72 FR 35673), we published the
proposed rule entitled, ‘‘Establishment
of Revisit User Fee Program for
Medicare Survey and Certification
Activities’’ and provided for a 60 day
comment period. This rule sets forth
final requirements and the final Fee
Schedule for providers and suppliers
who require a revisit survey as a result
of deficiencies cited during an initial
certification, recertification, or
substantiated complaint survey.
The Centers for Medicare & Medicaid
Services (CMS) has in place an
outcome-oriented survey process that is
designed to determine whether existing
Medicare-certified providers and
suppliers or providers and suppliers
seeking initial Medicare certification are
actually meeting statutory and
regulatory requirements, conditions of
participation, or conditions for
coverage. These health and safety
requirements apply to the environments
of care and the delivery of services to
residents or patients served by these
facilities and agencies. The Secretary of
the Department of Health and Human
Services (‘‘HHS’’) has designated CMS
to enforce the conditions of
participation/coverage and other
requirements with these programs. The
revisit user fee will be assessed for
revisits conducted in order to determine
whether deficiencies cited as a result of
carrying out CMS’s survey process
obligations have been corrected.
B. Requirements for Issuance of
Regulations
Section 20615(b) of The Continuing
Appropriations Resolution (‘‘Continuing
Resolution’’) budget bill passed by the
Congress and signed by the President
directed HHS to implement the revisit
user fees in FY 2007. Section 20615(b)
states as follows:
The Secretary of Health and Human
Services shall charge fees necessary to cover
the costs incurred under ‘Department of
Health and Human Services, Centers for
PO 00000
Frm 00002
Fmt 4701
Sfmt 4700
Medicare and Medicaid Services, Program
Management’ for conducting revisit surveys
on health care facilities cited for deficiencies
during initial certification, recertification, or
substantiated complaints surveys. Not
withstanding section 3302 of title 31, United
States Code, receipts from such fees shall be
credited to such account as offsetting
collections, to remain available until
expended for conducting such surveys (Pub.
L. 110–5, H.J.Res.20, § 20615(b)(2007)).
As directed by the Secretary, in the
June 29, 2007 Federal Register (72 FR
35673), CMS established revisit user
fees for revisit surveys and put forth in
regulation the definitions, criteria for
determining the fee, the fee schedule,
collection of fees, reconsideration
process for revisit user fees,
enforcement and regulatory language
addressing enrollment and billing
privileges, and provider agreements. In
the proposed rule, cost projections were
based on FY 2006 actual data and were
expected to amount to $37.3 million on
an annual basis. These calculations
were included in section IV Regulatory
Impact Analysis in the proposed rule
(72 FR 35678).
The fees will take effect on the date
of publication of the final rule and will
be in effect until the date that the
authority provided by the Congress
expires. At the time of publication of
this regulation the applicable date is
September 30, 2007. As discussed
thoroughly in the proposed rule, based
on the Congress’ knowledge of section
1864(e) of the Social Security Act and
already established survey and
certification activities, the unambiguous
nature of section 20615(b) of the
Continuing Resolution, and the
principles of lex posterior derogate legi
priori or ‘‘last-in-time’’ rule, the
Secretary has the authority to
implement this revisit user fee and
establish a final fee schedule. See 72 FR
35674–35675 (discussing section
1864(e) of the Social Security Act).
II. Summary of the Proposed Provisions
and Response to Comments
In the June 29, 2007 Federal Register
(72 FR 35673), we published the
proposed rule entitled, ‘‘Establishment
of Revisit User Fee Program for
Medicare Survey and Certification
Activities’’ and provided for a 60 day
comment period.
We received a total of 74 comments
from various providers, suppliers,
health care associations, and individual
health care professionals and other
individuals. The comments ranged from
general support of the survey process or
general opposition to the proposed
provisions to very specific questions or
comments regarding the proposed new
revisit user fee.
E:\FR\FM\19SER2.SGM
19SER2
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
Brief summaries of each proposed
provision, a summary of the public
comments we received and our
responses to the comments are set forth
below. Comments related to the
paperwork burden and the impact
analyses are addressed in the Collection
of Information and the Regulatory
Impact Analysis sections in this
preamble.
General Comments
1. Time Period for Levying Fees
Comment: Several commenters
suggested that CMS should not allow
user fees for nursing home revisits
beyond the end of the fiscal year. The
commenters believe that nursing homes
bear the brunt of the overall survey
process because surveys are conducted
annually for nursing homes and as such
CMS should ensure that the fee is not
renewed.
Response: The President’s HHS
budget for FY 2007, as enacted by the
Congress, directs the HHS Secretary to
implement the revisit user fees during
FY 2007. Since the provisions for the
revisit user fee were put forth through
the annual appropriations process,
continuation of the fees under this
regulation beyond September 30, 2007
will depend on Congressional renewal
or extension of the time period under
which fees may be assessed. While
nursing homes have the most frequent
surveys, they also have the largest
number of revisits. Revisits in nursing
homes represent the largest single
source revisit costs. While there would
be cost to some—but not all—nursing
homes as a result of the revisit fees,
nursing homes also benefit from being
able to reassure prospective nursing
home residents and their families that
the nursing home is federally certified
and that there is an objective and
independent system of oversight to
assure quality. The revisit survey is an
essential element of that quality
assurance system. We also note that the
revisit fees are not restricted to nursing
homes, but apply to almost all providers
and suppliers that require a revisit to
confirm that identified deficiencies are
remedied.
jlentini on PROD1PC65 with RULES2
2. Authority to Assess a Revisit User Fee
Comment: A few commenters
expressed concern that revisit fees
would be imposed when the authority
granted to levy fees expires on
September 30, 2007 and that there does
not appear to be legislation pending that
would extend CMS’ authority to impose
these fees beyond FY 2007. One
commenter stated that if the Congress
does not extend this authority, then it
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
appears that this rule will be void.
Another commenter disagrees with CMS
interpretation of section 1864(e) of the
Social Security Act (the Act) as giving
HHS the ‘‘authority to assess revisit user
fees.’’ The commenter felt that clearly
the inclusion and specific wording in
this section within the Act indicates
Congress intended that the Secretary
‘‘may not impose’’ any fee on any
facility for any survey (revisit or
otherwise) for determining compliance
‘‘with any requirement of this title.’’
Response: We are frequently expected
to implement legislation that is
promulgated by the Congress and
therefore has the force of law, as in the
passed FY 2007 appropriations bill. We
strive to implement the provisions in an
efficient and effective manner once it
becomes law. The commenter is correct
that the current authority to impose the
revisit user fee expires for revisits
occurring after September 30, 2007,
unless otherwise authorized via
legislation or through the FY 2008
appropriations bill, as examples. The
revisit user fee is included in the
President’s proposed FY 2008 budget.
We acknowledge the commenter’s
disagreement with the Congress’ intent
as it relates to authority to impose any
fee based on the Social Security Act.
However, as we discussed in the
Proposed Rule, we believe that Congress
intended to give the Secretary authority
to implement this revisit user fee
program when Congress enacted section
20615(b) of the Continuing Resolution.
3. ‘‘Good Performers Versus Poor
Performers’’
Comment: Several commenters
believed that those nursing homes
considered to be providing excellent
care would be required to pay a revisit
user fee along with nursing homes that
are considered poor performers. The
commenters believe that even minor
infractions uncovered during an annual
survey for these higher quality nursing
homes would still lead to the imposition
of a revisit user fee. A commenter
questioned whether or not those
facilities going above and beyond to
provide higher level care through higher
costs of operations should be subjected
to this user fee in the same manner as
those facilities that are performing at the
bare minimum requirements with lower
costs of operations if the goal is to
promote a better health care
environment.
Response: We believe that many
nursing homes will pay no revisit user
fees because they consistently provide
high quality care, have no deficiencies
identified through the survey process,
and therefore will require no revisits.
PO 00000
Frm 00003
Fmt 4701
Sfmt 4700
53629
Other nursing homes may require some
revisits but with minimal costs because
the deficiencies are not serious, and the
revisit may be accomplished through an
offsite survey. We have established a
much lower fee for offsite surveys since
actual costs to the survey program for
these revisit surveys are much less than
the costs for onsite surveys, and the user
fee is intended only to recoup average
actual costs. We believe we have
designed the user fee program to result
in a positive correlation between quality
of care and amount of the fees—the
better the quality of care, the lower the
fees. We also expect that the prospect of
fees for revisits will promote greater
compliance with federal quality of care
requirements, thereby making for fewer
revisits and fewer fees over time.
4. Revisit User Fee Compared to Penalty
Comment: Several commenters
believe the revisit user fee constitutes a
penalty regardless of whether cited
deficiencies are appealed and
overturned. They also stated that the
revisit user fee imposed additional
penalties that may be assessed.
Response: The revisit user fee does
have some similarities to a quality of
care penalty in so far as the revisit user
fee only applies to providers or
suppliers for which deficiencies have
been identified. There are differences,
however, between the revisit user fee
and traditional penalties. For example,
a traditional penalty, such as a civil
monetary penalty, is assessed according
to the scope and severity of individual
deficiencies that have been identified. A
penalty amount would be independent
of the cost for the time required by
surveyors to revisit the provider in order
to confirm that corrections have been
made. In contrast, the revisit user fee is
designed only to replace the average
actual cost associated with the revisits
themselves. Second, currently only
nursing homes are subject to civil
monetary penalties; no other Medicarecertified providers or suppliers affected
by this regulation are subject to CMS
CMPs for quality of care deficiencies at
this time. Among nursing homes, only
approximately 12 percent of nursing
homes are levied a CMP in any
particular year, on average. If a revisit
survey is required, a user fee will be
assessed; however this does not
necessarily mean a CMP will be levied
as well.
5. Revisit User Fee Compared to Taxes
Comment: One commenter stated that
the revisit user fee amounted to a new
tax. Another commenter felt that the
revisit user fee was an example of
extortion and that the funding to
E:\FR\FM\19SER2.SGM
19SER2
53630
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
jlentini on PROD1PC65 with RULES2
administer the survey process including
revisits is already in place. They
equated this fee to have the same effect
as if the IRS was to impose a fee when
the individual’s tax return is flagged for
an audit. A commenter felt the fee
would amount to financial impropriety
on the part of the government.
Response: We believe that the
commenter’s characterization of the
revisit user fee as a ‘‘tax’’ is not
accurate. Taxes are typically imposed
regardless of whether the taxed parties
actually use the services that the tax
makes possible. Taxes must be paid
regardless of the extent of government
services that are accessed. In contrast,
the revisit user fee will be levied only
for those who fail to comply fully with
their responsibilities to provide quality
care and to abide by federal quality of
care and related requirements under the
Medicare Provider Agreement and
applicable regulations and laws for
providers and suppliers. Such failure
obliges CMS to incur revisit survey costs
that would not otherwise have been
incurred. The revisit user fee amount is
calibrated to match the additional
resources required, on average, for the
surveyors to verify compliance with
known federal requirements subsequent
to the provider’s or supplier’s initial
failure to meet those requirements fully.
6. Effects on Resident or Patient Care
Comment: Several commenters raised
concern that the assessment and
payment of the user fee would remove
several thousand dollars per facility that
otherwise would be available for
resident care. Another commenter felt
the ethics of this proposal would
adversely affect the citizens of a State.
The commenter felt that the revisit user
fee was unfair. Other commenters
stated, in various ways, that the revisit
user fee would remove valuable
resources that would otherwise be
expended for patient and employee
resources. They felt that a direct
drawdown from funds used for patient
care would occur, resulting in no
improvement to the quality of resident
care. Finally, they felt that there would
be a direct adverse fiscal impact on
smaller more financially challenged
facilities.
Response: CMS believes the providers
and suppliers are the controlling agents
in managing the quality of care of
services provided in their healthcare
facilities. Providers and suppliers may
avoid revisit fees by ensuring sustained
compliance with federal quality of care
requirements. The revisit user fees
simply compensate for the costs of
confirming that previously-identified
problems have been remedied. The
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
certainty that a revisit will occur is a
substantial incentive for a provider to
make the necessary corrections;
therefore, we believe that this quality
assurance function will improve care
and safety for Medicare beneficiaries. In
addition, we believe the imposition of
revisit user fees will likely encourage a
sustained commitment to management
systems that improve quality of care
provided to all clients served by the
provider. CMS does not believe that the
revisit user fee should harm quality of
care provided, but can instead become
a valuable, additional incentive to
encourage providers and suppliers to
commit to sustained compliance with
federal quality of care requirements. The
quality of care message is that providers
and suppliers will have no user fees
when quality of care meets the
appropriate federal standards. To the
extent that there are deficiencies,
providers and suppliers will have only
small fees to the extent that the
deficiencies are not serious or
widespread. If quality problems do
occur, providers and suppliers will have
greater incentives to ensure that quality
lapses are corrected more quickly than
in the past, since the revisit fees will be
less if only one revisit is required.
7. State Practices and Incentives for
Revisits
Comment: Several commenters
expressed a concern that State survey
teams would be instructed to find more
violations if a revisit user fee were in
place, thus increasing the number of
revisit surveys. One commenter also
raised the concern that the facility will
have to pay a revisit user fee for a revisit
survey although the State may not
consider the deficiency severe. Another
commenter raised concern that there
would be tremendous potential for
abuse, that surveyors lacked experience
and that there existed too much
financial control of the facilities in the
hand of the state surveyors. This
commenter also expressed concern as to
whether there would be adequate
monitoring of State agencies for
potential abuse of this program. Two
commenters believed the fee would
increase the number of revisits currently
being done, putting an extra burden on
staff as well as required additional time
for State surveyors. One commenter felt
that the nursing home revisits would
increase to 100 percent because of what
they consider a financial incentive.
Response: We agree that any potential
conflict of interest, and any appearance
of conflict of interest, must be addressed
in the design and operation of any user
fee program. A number of safeguards
will prevent any such potential conflict
PO 00000
Frm 00004
Fmt 4701
Sfmt 4700
from becoming a serious reality. First,
the revisit user fees will be collected
nationally by CMS through a contractor
rather than by individual States. CMS
makes allocations to States based on the
effects of inflation and on overall survey
and certification workload and
performance for all survey and
certification functions, with revisits
comprising just one of many functions.
The national survey and certification
budget may not exceed the level
established by Congress, regardless of
the level of revisit fee collections.
Second, all States must conduct revisits
according to policies and procedures
established by CMS. Those policies and
procedures are publicly available in
CMS’ State Operations Manual (SOM)
and in numbered Survey &
Certifications policy memoranda
published on the CMS Web site. Such
policies and procedures define the
circumstances under which revisit
surveys, both onsite and offsite, occur
and when they do not occur. CMS
Regional Offices monitor State
implementation of the policies and
procedures. We intend to increase CMS
monitoring for revisits. Third, States
incur substantial costs in order to
conduct revisits. Such costs are not
lightly undertaken, since there are
formidable natural and governmental
constraints on a State survey agency’s
ability to make use of any added funds
that might conceivably become available
even if there were a direct fiscal
connection between revisits and the
amount of money the State survey
agency were to receive. The single
largest cost to a State survey agency, for
example, is personnel. The ability of a
State survey agency to hire new staff
(even when new revenue becomes
available) is either very limited or there
is a long delay between the availability
of such funds and the hiring of a
surveyor. Once hired, the surveyor must
typically undergo about six months of
training and observing before being
entrusted to conduct surveys. These
constraints make it unlikely that a State
survey agency would incur the upfront
staffing costs of conducting revisits that
were not required, or would seek to
identify more deficiencies simply to
justify a revisit and hope that at some
vague future date the added costs might
be recognized by CMS. To the extent
that the revisit user fee does create any
type of new incentive, we expect that
the main incentive will be for providers
and suppliers to maintain compliance
with federal quality of care and safety
requirements, since such compliance
offers a clear pathway to the avoidance
of revisit fees.
E:\FR\FM\19SER2.SGM
19SER2
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
jlentini on PROD1PC65 with RULES2
Comment: One commenter stated that
the proposed rule would increase fees
for facilities that had follow-up for
routine licensure/certification surveys
as well as complaint visits.
Response: Revisit user fees will apply
only to surveys that occur after an initial
certification, recertification, or
substantiated complaint survey has
identified deficiencies. State licensures
issues that a State survey agency might
address during a survey or a revisit
survey are separate activities not
connected with the assessment of a
revisit user fee. Surveyor time spent on
State-only issues must also be costaccounted for by State survey agencies
to ensure that such costs are not billed
to the federal government. Thus, a
survey or revisit survey based solely on
State licensure requirements would not
create the assessment of a revisit user
fee. Only the need to conduct revisit
surveys regarding Federal conditions of
participation, requirements, or
conditions for coverage would trigger a
revisit user fee.
Comment: One commenter observed
that State and federal regulations
require nursing facilities to report
allegations of abuse and other issues to
the State survey agency. The commenter
expressed concern that such mandatory
reports will result in a visit from the
Survey Agency inspectors, usually
without any finding of regulatory
deficiencies. The financial impact of the
proposal could be very burdensome for
many nursing facilities.
Response: An initial visit to
investigate a complaint, such as the
allegation of abuse and or neglect
mentioned by the commenter would not
trigger a revisit user fee. A revisit would
be required only if a deficiency is
identified as a result of that complaint
investigation. The user fee would not
apply to the initial complaint
investigation; it would apply only to the
revisit once the provider has alleged to
the State survey agency that it has
addressed the deficiency identified in
the original complaint investigation.
Complaint investigations that find no
deficiencies will not require any revisits
and will therefore not occasion any
revisit fees.
8. Revenue Seeking—Government
Responsible for Funding Survey Process
Comments: Several commenters felt
that this proposed rule and the
assessment of revisit user fees was a
revenue seeking mechanism, that it was
a way to fund and pay for the survey
process. Many of these same
commenters felt that the obligation of
the survey process and the conducting
of revisit surveys was that of the Federal
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
government, and or the State Health
Departments. The government has
mandated these surveys and as such the
quality assurance checks are its
obligation. One commenter felt that the
Federal government’s role is to raise
these funds, as been often done through
Federal taxes, although not advocating a
Federal tax increase, it is through these
like efforts the commenter suggested
that funds should be derived to pay for
the survey process.
Response: The revisit user fee is
designed simply to pay for actual costs
of conducting revisits, on average, rather
than as a revenue generating instrument
that might be unconnected with the
government activity for which the
revisit user fee is assessed. In addition,
the revisit user fees offer the ancillary
benefit of encouraging providers and
suppliers to commit to sustained
compliance with Federal quality of care
requirements and ensure that quality
lapses are remedied quickly.
9. Creating Positive Incentives
Comment: Although some
commenters felt the revisit user fee was
punitive in nature and not proactive,
several commenters did support added
incentives to increase patient and
resident safety, quality of care, and
compliance to standards. A couple of
commenters went on to state that a
positive incentive would serve to
strengthen the relationship between
regulators and providers and would
establish CMS as a partner rather than
an adversary of the long-term care
community. A few commenters
indicated strong support of the
Medicare survey process as one method
to assure only providers and suppliers
that offer high quality services
participate in the Medicare program.
One commenter went as far as offering
three goals for which the collected user
fees should be directed, which included
improving consistency of the survey
process, ensuring complete, providerspecific training for surveyors, and
improving communication between
State survey agencies and the provider
community on survey rules and
expectations. This commenter went on
to state that fees derived for these
survey program improvements should
not be used to merely supplant the
normal funding stream but dedicated to
specific programs.
Response: The intent of the revisit
user fee program is to recover the costs
associated with conducting follow-up
visits for deficiencies cited during
initial certification, recertification, and
substantiated complaint surveys.
Although the commenter offers three
additional goals for the collected revisit
PO 00000
Frm 00005
Fmt 4701
Sfmt 4700
53631
user fee, we believe that those admirable
goals go beyond Congress’ intended
purpose of the revisit user fee program.
Part 424—Conditions for Medicare
Payment
Subpart P—Requirements for
Establishing and Maintaining Medicare
Billing Privileges
Section 424.535 Revocation of
Enrollment and Billing Privileges in the
Medicare Program
We proposed to amend § 424.535(a)(1)
by adding a new sentence to the criteria
for which a provider or supplier may be
determined not in compliance and for
which we may revoke enrollment and
billing privileges in the Medicare
program. We proposed to add that the
provider or supplier may also be
determined not to be in compliance if it
has failed to pay any user fees as
assessed under part 488 of this chapter.
The paragraph will continue to read that
all providers and suppliers are granted
an opportunity to correct the deficient
compliance requirement before a final
determination to revoke billing
privileges occurs.
Comment: Some commenters tied in
the discussion of revocation of billing
and the termination for nonpayment as
proposed in § 488.30(f) and
§ 489.53(a)(16). One commenter felt that
termination for nonpayment within 30
days is power disproportionate to the
offense and is unrelated to quality of
care and safety issues. Another
commenter felt that this provision is
reason not to participate in Medicare, or
to care for Medicare patients.
Response: While we proposed that a
provider or supplier may also be
determined not to be in compliance if a
revisit user fee payment has not been
received within 30 calendar days after
receipt of the notice that payment is
due, we also state at § 424.535(a)(1) that
all providers and suppliers are granted
an opportunity to correct the deficient
payment compliance before a final
determination is made to revoke billing
privileges. We further note that a
payment-due notice from CMS is
preceded by a survey or complaint
investigation that has found
deficiencies, a correction period
afforded to the provider or supplier, a
revisit to confirm compliance, then a
later issuance of the payment-due
notice, followed by the formal 30-day
advance notice to the provider. As soon
as a revisit occurs, each provider or
supplier will know that a revisit user fee
will follow at a later date, will know the
amount of the fee due from the fee
schedule published in this rule, and
will know that the payment will be due
E:\FR\FM\19SER2.SGM
19SER2
53632
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
within 30 calendar days. While the rule
specifies that enforcement action may
occur if the bill has not been paid
within 30 calendar days, the total
amount of planning time available to the
provider or supplier will have totaled
much more than the 30 calendar day
period before any enforcement action
may occur. Finally, the revocation of
billing and enrollment privileges is not
an immediate action upon the failure of
a provider or supplier to remit the
assessed revisit user fee. In this final
rule we therefore retain the time frames
for which action will occur regarding
this process and retain the amended
language to § 424.535(a)(1) as final.
Part 488—Survey, Certification, and
Enforcement
Subpart A—General Provisions
Section 488.30 Revisit User Fee for
Revisit Surveys
We proposed a new § 488.30 which
set forth proposed regulations that
identifies the circumstances under
which providers or suppliers be
assessed a user fee for revisit surveys
connected with deficiencies identified
during surveys for initial certification,
recertification, or substantiated
complaints. This proposed paragraph
identifies the assessment of fees, criteria
for which the proposed fee schedule
will be based, and collection of fees.
jlentini on PROD1PC65 with RULES2
Section 488.30(a)—Definitions
We proposed in § 488.30(a) to define
terms associated with this paragraph.
Those terms included: ‘‘certification,’’
‘‘complaint surveys,’’ ‘‘substantiated
complaint survey,’’ ‘‘provider of
services,’’ ‘‘provider,’’ ‘‘supplier,’’ and
‘‘revisit survey.’’ Many of the comments
received for § 488.30(a) dealt less with
the wording in the definitions and more
with the survey and certification
activities and its process.
Certification (Initial or Recertification)
We proposed that ‘‘certification’’
(both initial and recertification) would
include those activities as defined in
§ 488.1. ‘‘Certification’’ as currently
defined in § 488.1 is a ‘‘recommendation
made by the State survey agency on the
compliance of providers and suppliers
with the conditions of participation,
requirements (SNFs and NFs), and
conditions for coverage.’’
Comment: One commenter proposed
that home health agencies and hospice
facilities be removed from initial
certifications since it can take 2 or more
years to get initial certifications.
Another commenter proposed that the
revisit user fee should be expanded to
include initial surveys of ESRD facilities
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
to allow more timely surveys that now
are delayed due to CMS budget, staff
shortages, and other priorities.
Response: Both commenters are
referring to the issue of initial
certification surveys conducted for new
providers or suppliers, rather than the
revisit surveys themselves.
While we appreciate the suggestion
from one commenter that CMS charge a
fee for initial surveys so as to eliminate
the current backlog of unsurveyed and
uncertified potential Medicare
providers, we are neither authorized by
Congress nor prepared to charge such
fees at this time.
We also do not accept the suggestion
from the other commenter that home
health agencies and hospices simply be
exempt from initial certification due to
the survey backlog. We are not
authorized to make such exemption. We
also believe an exemption would be
inadvisable, as it would permit those
providers to begin to serve Medicare
beneficiaries without any assurance that
they meet quality of care and safety
requirements. The proliferation of new
home health and hospices in a few
States have also given rise to
considerable concerns of fraud, a
concern that CMS is responding to
through various anti-fraud initiatives
recently announced by the Secretary.
We do expect that the revisit user fee
will indirectly help to resolve the
problem of surveying and certifying new
providers. Revisit costs represent a
minority but still substantial portion of
overall survey and certification
expenses. By defraying such costs
through the user fees, the States will
then be in a better position to conduct
tier III and tier IV priority work, and
will be able to conduct more initial
surveys than they have been able to
conduct recently.
While we appreciate the comments, to
adhere to the Congress intent within the
Continuing Resolution, we will not
assess a fee for initial certification, nor
at this time can we remove providers or
suppliers based on when initial
certifications are conducted. We will
retain the proposed definition of
‘‘certification’’ as final.
‘‘Complaint Surveys’’
We proposed that complaint surveys
are those surveys conducted on the
basis of a ‘‘substantial allegation of
noncompliance,’’ as defined in § 488.1.
The term ‘‘substantial allegation of
noncompliance’’ means:
A complaint from any of a variety of
sources (including complaints submitted in
person, by telephone, through written
correspondence, or in newspaper or
magazine articles) that if substantiated,
PO 00000
Frm 00006
Fmt 4701
Sfmt 4700
would affect the health and safety of patients
and raises doubts as to a provider’s or
supplier’s noncompliance with any Medicare
condition. (42 CFR § 488.1)
We further noted that the Continuing
Resolution included the term
‘‘substantiated complaints surveys.’’ We
proposed that ‘‘substantiated complaint
survey’’ means a complaint survey that
results in the proof or finding of
noncompliance at the time of the
survey, a finding that noncompliance
was proven to exist, but was corrected
prior to the survey, and includes any
deficiency that is cited during a
complaint survey, whether or not the
deficiency was the original subject of
the substantial allegation of
noncompliance.
We proposed that a user fee would be
assessed for revisit surveys conducted to
evaluate the extent to which
deficiencies identified during a
substantiated complaint survey have
been corrected.
Comment: Commenters requested
clarification on the term ‘‘substantial
allegation of noncompliance,’’ and felt
that the definition as a basis for the
revisit fee is vague and open-ended.
Response: CMS proposed the
definition for ‘‘complaint surveys’’ to
mean those surveys conducted on the
basis of a substantial allegation of
noncompliance, as defined in § 488.1.
‘‘Substantial allegation of
noncompliance’’ has been the term used
in current survey, certification, and
enforcement procedures and as such we
intended to maintain a level of
consistency by utilizing this definition
as a means to define ‘‘complaint
surveys.’’ It is this process that generates
the action for which an investigation
into the complaint should occur. It is
the substantiation of this complaint
survey that will determine if a revisit
survey should be conducted and as a
result a revisit user fee should be
assessed. As we provided in the
discussion of the proposed rule
‘‘substantiated complaint survey’’
means a complaint survey that results in
(1) the proof or finding of
noncompliance at the time of the
survey, (2) a finding that noncompliance
was proven to exist, but was corrected
prior to the survey, and (3) includes any
deficiency that is cited during a
complaint survey, whether or not the
deficiency was the original subject of
the substantial allegation of
noncompliance. If any of these 3
situations are determined and a revisit
is required as a result of the situation,
then a revisit user fee will be assessed.
It will not simply be based on whether
the complaint was substantiated. A
complaint may be substantiated without
E:\FR\FM\19SER2.SGM
19SER2
jlentini on PROD1PC65 with RULES2
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
being determined to be non-compliant
with the regulations. The substantiation
of a complaint is a separate issue from
the determination of compliance with
the regulations and thus the triggering of
a revisit user fee.
Comment: One commenter contends
that accepting complaints from a variety
of sources is overly broad and permits
the process to go forward at great length.
Another commenter felt that there is
nothing to prevent disgruntled
employees from submitting complaints
anonymously, especially once they
learn that the user fee will punish the
facility. Commenters felt that this
provides incentive for surveyors to
substantiate the compliant that triggered
the revisit or substantiate another
deficiency.
Response: We do not expect that
either the quantity of complaints
received or the source of the complaints
will affect revisit user fees to any
measurable extent. The revisit user fee
does not apply to any complaint
investigation. Only complaints which
have been substantiated as showing
non-compliance with Federal
requirements will result in citation of a
deficiency. Only those deficiencies that
require a revisit survey will then trigger
a revisit user fee. When multiple
complaints are received near the same
point in time, State survey agencies
typically bundle those together in one
complaint investigation, this
investigation is followed by a revisit
survey only if one or more of the
complaints is substantiated and the
agency finds noncompliance to such an
extent that a revisit is called for
according to CMS policy. Finally, the
volume of complaints reaching CMS are
to some extent affected by the extent
that the provider or supplier has an
effective system of inviting complaints
internally, and responding to
complaints effectively such that
beneficiaries or their families feel that
there is less need to file complaints with
CMS or any external party. We believe
that beneficiary complaints represent a
very important source of feedback for
providers, suppliers, CMS and States.
We hope such feedback can be
effectively used by us and others to
identify areas of health care that merit
serious attention.
Comment: One commenter disagreed
that a ‘‘substantiated complaint survey’’
can cite any deficiency regardless of
whether that deficiency was the original
subject of the complaint. Two
commenters raised concerns that a
revisit user fee will be imposed even in
cases where a ‘‘substantiated
complaint’’ is corrected prior to the
survey or that CMS would require a
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
revisit user fee in this instance and this
would discourage a facility’s internal
quality assurance. A commenter raised
the questions as to whether a
substantiated complaint included
condition and standard levels or just
condition level. This commenter
proposes that it just include condition
level since those levels result in noncertification or decertification.
Response: CMS published condition
of participation, condition for coverage
and other regulatory requirements
typically take the form of specific
standards, with multiple standards
related to a common topic comprising a
broader ‘‘condition.’’ Revisit surveys are
almost always required for conditionlevel deficiencies and are also often
required for standard-level deficiencies,
depending on the extent and
seriousness of the noncompliance
identified. As we provided in the
discussion of the proposed rule,
‘‘substantiated complaint survey’’
means a complaint survey that results in
(1) the proof or finding of
noncompliance at the time of the
survey, (2) a finding that noncompliance
was proven to exist, but was corrected
prior to the survey, and (3) includes any
deficiency that is cited during a
complaint survey, whether or not the
deficiency was the original subject of
the substantial allegation of
noncompliance. If any of these 3
situations are determined and a revisit
is required as a result of the situation
then a revisit user fee is assessed.
Although we disagree in part with the
commenter who indicated that any
deficiency can not be cited during a
complaint survey, we reiterate and
clarify that under our current policy for
conducting complaint surveys, we do
require that if a State surveyor in the
course of conducting the complaint
survey observes a situation that
warrants further investigation, that the
State must seek input from the CMS
regional office to request permission to
further pursue this additional situation.
See U.S. Centers for Medicare &
Medicaid Services. State Operations
Manual, ‘‘Complaint Procedures.’’
ONLINE. 2006. CMS. Available: https://
www.cms.hhs.gov/manuals/downloads/
som107c05.pdf (‘‘SOM-Complaint’’).
With regard to the two commenters’’
concern that a finding that
noncompliance was proven to exist, but
was corrected prior to the survey, this
situation alone would not trigger a
revisit user fee. In addition, because a
substantiated complaint survey can
include the above criteria we do not
believe at this time that we should make
a distinction between a condition level
deficiency and a standard level
PO 00000
Frm 00007
Fmt 4701
Sfmt 4700
53633
deficiency. As a continued part of the
survey and certification process a
complaint may be substantiated without
being determined to be non-compliant
with the regulations. The substantiation
of a complaint is a separate issue from
the determination of compliance with
the regulations and thus the triggering of
a revisit user fee.
We appreciate the comments,
however to adhere to consistency across
current survey and certification policy,
we will retain the definition of
‘‘complaint surveys’’ to mean those
surveys conducted as the basis of a
substantial allegation of noncompliance,
as defined in § 488.1 as final.
‘‘Provider of Services, Provider, or
Supplier’’
We proposed to retain the terms
‘‘provider of services,’’ ‘‘provider,’’ or
‘‘supplier’’ as defined in § 488.1. We
proposed that all ‘‘provider of services,’’
‘‘providers,’’ or ‘‘suppliers,’’ as defined
in § 488.1, will be subject to user fees,
unless otherwise exempted through the
final rule. We proposed that a ‘‘provider
of services’’ or ‘‘provider’’ that may be
assessed a user fee, as it applies in this
proposed rule, includes a hospital,
critical access hospital, skilled nursing
facility, dually-participating nursing
facility (‘‘SNF/NF’’), home health
agency (‘‘HHA’’), and hospice.
Transplant centers would also be
subject to user fees and have been
defined in § 482.70 of this chapter. We
proposed that ‘‘providers of services’’ or
‘‘providers’’ that will not be assessed a
revisit user fee as defined in the
proposed rule to be comprehensive
outpatient rehabilitation facilities,
transplant centers, and providers of
outpatient physical therapy or speech
pathology services. These providers are
excluded from this rule because they are
not subject to a routine survey process
as are other service providers. We stated
that Medicaid-only ‘‘providers of
services’’ or ‘‘providers’’ will not be
assessed a user fee.
We proposed a ‘‘supplier’’ that may be
assessed a user fee, as it applies in the
proposed rule includes an end-stage
renal disease center, a rural health clinic
(‘‘RHC’’), and an ambulatory surgical
center (‘‘ASC’’). ASCs must have an
agreement with CMS to participate in
Medicare and must meet conditions for
coverage as defined in Part 416 of this
chapter.
‘‘Suppliers’’ that would not be
assessed a user fee under the proposed
rule are independent laboratories,
portable x-ray centers, physical
therapists in independent practice,
Federally Qualified Health Centers
(FQHCs), and chiropractors. These
E:\FR\FM\19SER2.SGM
19SER2
jlentini on PROD1PC65 with RULES2
53634
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
suppliers are excluded because they are
not subject to a routine survey process
as are other suppliers. We stated that
Medicaid-only ‘‘suppliers’’ will not be
assessed a user fee.
The proposed rule would not interfere
with user fees associated with clinical
laboratories as established by the
Congress, which passed the Clinical
Laboratory Improvement Amendments
(CLIA) in 1988 and established that
outpatient clinical laboratory services
are paid based on a fee schedule in
accordance with section 1833(h) of the
Act.
We received several comments
regarding our definition of ‘‘provider of
services,’’ ‘‘provider,’’ or ‘‘supplier’’ and
we have included them below.
Comment: One commenter indicated
that Chiropractors status among the
Allied Health Care professions remains
in dispute, this commenter contends
that Chiropractors should be excluded
from any Medicare provider list.
Response: Our current regulations
found in § 488.1 include Chiropractors
as identified as a supplier. This
particular definition section also has
extensive implications in various parts
of the Medicare and Medicaid program
and although we appreciate the
commenter’s concern, we do not
propose to remove chiropractors from
the definition of supplier. We do
reiterate that Chiropractors are not
subject to the revisit user fees.
Comment: One commenter believed
that the implementation of this rule
should not coincide with the
publication of the final rule for ESRD
conditions of coverage. This commenter
felt that revisits and assignment of fees
could very well be excessive during the
‘‘learning curve’’ of the new regulation;
if CMS has such discretion the
commenter suggests that this final rule
should state that revisit user fees for
ESRD facilities will not apply for the
first 12 months of implementation of
new conditions for coverage.
Response: The commenter is referring
to the future publication of the final
CMS rule revising the Conditions for
Coverage for end stage renal disease
facilities (ESRD). New rules or
substantial revisions of new rules are
typically promulgated with future
effective dates. Considerable
educational communications usually
precede the effective date, during which
providers or suppliers have an
opportunity to become familiar with the
rule and make necessary changes before
the survey process holds them
accountable. Currently, ESRD surveys
are conducted about once every three to
five years. We therefore believe that
there will be reasonable opportunities
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
for providers to adjust to the new rules
before they are affected by surveys and
the later revisits that might follow some
surveys. Finally, although we appreciate
the commenter’s suggestion, we do not
have the discretion at this time to
exclude ESRD facilities from this final
rule. ESRD facilities and revisits costs
were included within the President’s
budget projections and mandated by the
Congress.
Comment: One commenter expressed
concern that religious nonmedical
health care institutions (RHNCIs) would
be subject to the revisit user fees.
Response: We appreciate the
comment received. We inadvertently
did not include religious nonmedical
health care institutions (RHNCIs) in the
definitions. RHNCIs should have been
included, as they are subject to the
survey and certification process. To
adhere to the intent of the Congress and
maintain consistency of definitions
across Medicare and Medicaid
programs, we will retain the definitions
as proposed with the exception that we
will include RHNCIs in the definition.
However, in the fee schedule in this
final rule we exempt them from the user
fee program due to the very small
number of such facilities and their
relatively unusual nature. Any change
to the exemption status would be
preceded by publication of a Federal
Register notice. The final definition of
‘‘provider of services,’’ ‘‘provider,’’ or
‘‘supplier’’ will read ‘‘Provider of
services, provider, or supplier’’ as
defined in § 488.1, and ambulatory
surgical centers, transplant centers, and
religious nonmedical health care
institutions subject to § 416.2, § 482.70,
and § 403.702 of this chapter,
respectively, will be subject to user fees
unless otherwise exempted.
‘‘Revisit Survey’’
In the Proposed Rule CMS defined the
term ‘‘revisit survey’’ to mean a survey
performed with respect to a provider or
supplier cited for deficiencies during an
initial certification, recertification, or
substantiated complaint survey and
which is designed to evaluate the extent
to which previously cited deficiencies
have been corrected. We further
proposed that for purpose of this rule
revisit surveys include both offsite and
onsite. We also reiterated that
regulations established in § 488.26 of
this same part provided regulatory
requirements for conditions of
participation, conditions for coverage,
or other regulatory requirements.
Specifically § 488.26 of this part states
that the compliance determination is
made by the State survey agency and
includes a survey process that assesses
PO 00000
Frm 00008
Fmt 4701
Sfmt 4700
compliance with Federal health, safety,
and quality standards.
We received only a few comments
regarding the term ‘‘revisit surveys’’ and
received the majority of comments
under this section reflecting
commenters concern regarding the
survey process and the manner in which
revisit user fees will be assessed.
1. ‘‘Revisit Survey’’ Term
Comment: Several commenters
requested that we redefine the term
‘‘revisit survey’’ so that the definition
does not include desk reviews or offsite
surveys, that the offsite (desk) reviews
be defined, that fees only be imposed if
the survey is done in accordance with
already established policies per
provider type, that the definition
include criteria about when onsite
revisits are required, and that we limit
the fees to ‘‘onsite revisit surveys.’’
Response: We included offsite revisit
surveys (desk reviews) because we
wished to retain the option of the offsite
revisit surveys where warranted, since
the cost to providers and suppliers
under the revisit fee program will be
substantially less than for onsite revisit
surveys. The function of onsite and
offsite (desk review) revisit surveys is
the same. We interpret both types to
constitute revisits within the meaning
intended by Congress. The Continuing
Resolution requires fees to be assessed
that are necessary to cover the costs
incurred for conducting revisit surveys
on health care facilities cited for
deficiencies found during initial
certification, recertification, or
substantiated complaint surveys. As we
observed, we do not interpret this to
mean onsite revisit surveys only. Within
the current survey process itself there
are distinctions made for when an
onsite or offsite revisit survey should
occur and distinctions are made by
provider and supplier type. See U.S.
Centers for Medicare & Medicaid
Services. State Operations Manual,
‘‘Survey and Enforcement Process for
Skilled Nursing Facilities and Nursing
Facilities,’’ Online. 2004. CMS.
Available: https://www.cms.hhs.gov/
manuals/downloads/som107c07.pdf,
and also ‘‘Additional Program
Activities,’’ Online. 2007. CMS.
Available: https://www.cms.hhs.gov/
manuals/downloads/som107c03.pdf.
We disagree that revisit surveys
should only be those that were
conducted onsite, as there are situations
in which offsite reviews are required to
verify that the contents of the plan of
correction or the corrective action took
place. We do, however, agree that a
review of a plan of correction that does
not require verification beyond the plan
E:\FR\FM\19SER2.SGM
19SER2
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
of correction document itself would not
constitute an offsite revisit survey (as
defined here), and thus the provider or
supplier would not be assessed a revisit
user fee in such a circumstance. A
provider or supplier will be assessed a
revisit user fee for an offsite revisit
survey if the deficiency or deficiencies
cited are of a nature that the content of
the plan of correction and the
statements made by the provider or
supplier require verification and offsite
follow-up to ensure that the corrective
action has brought the provider back
into compliance with federal
requirements.
We appreciate the comments
received; however on the term ‘‘revisit
survey,’’ based on our discussion we
will retain the proposed definition of
‘‘revisit survey’’ as final.
jlentini on PROD1PC65 with RULES2
2. Survey Process
CMS discussed the current revisit
policy and survey and certification
process already established for all
providers and suppliers. We identified
current policy for skilled nursing
facilities and dually-participating
nursing facilities, performed at the
discretion of CMS or the State. This
revisit policy indicates circumstances
for which onsite revisits must occur for
certifying compliance and
circumstances when onsite revisits are
discretionary. Likewise, CMS generally
permits only two revisits for hospitals,
home health agencies, hospices,
ambulatory surgical centers, rural health
clinics, and end-stage renal disease
centers. Of these two revisits permitted
by CMS, one revisit should occur within
45 calendar days of the initial
certification, recertification, or
substantiated complaint survey, and one
revisit subject to CMS approval,
between the 46th and 90th calendar
days. See 72 FR 35676 (discussing
revisit policy, including discussion on
revisits related to Immediate Jeopardy).
2A. Survey Process: Skilled Nursing
Facilities and Dually-Participating
Nursing Facilities
Comment: Several commenters
contended that the survey process is
inconsistent and subjective, and
proposed that the revisit user fees be
postponed until these process issues are
resolved. Another commenter felt that
revisit user fees represent punishment,
especially when deficiencies are
erroneously cited. Two commenters
requested assurances that only
legitimate deficiencies will be cited, that
unnecessary revisits will not be
conducted, and that revisits will not be
conducted solely for the purpose of
collecting user fees. One commenter felt
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
that the proposed rule will complicate
the subjectivity and variability that will
always be part of the survey process.
Another commenter indicated that the
survey process is broken and subjective,
and as such, fees for revisits would be
unfair until those problems are resolved.
Response: CMS continuously works
with States to ensure that surveys are
applied as consistently as possible. CMS
also operates a national internal
consistency program in which
validation surveys are conducted by
Federal surveyors to promote optimum
consistency. For example, Federal
surveyors conduct validation surveys on
a 5% sample of nursing home surveys
to check the accuracy and adequacy of
State surveys. CMS then works with the
States to adjust for any significant
disparities. The issue of consistency is
also monitored as part of CMS’s review
of State performance. Because no system
is perfect, nursing homes have an
opportunity to request review of any
cited deficiency through a structured
informal dispute resolution process.
CMS takes the issue of consistency
seriously, and we continue to develop
additional methods to analyze and
address consistency issues, one example
is the new Quality Indicator Survey
(QIS) process that has been pilot-tested
in five States. The QIS process utilizes
customized software and is designed as
a staged process for use by surveyors to
systematically review requirements and
objectively investigate all triggered
regulatory areas in an effort to meet
several objectives, one of which is to
improve consistency and accuracy of
quality of care and quality of life
problem identification. We believe that
the revisit user fee will help address
those limitations and make more
feasible a number of additional
consistency improvements that are
underway.
Comment: One commenter feared that
there are no constraints to prevent a
surveyor from citing an already
corrected problem in order to trigger a
revisit. One commenter believed that
the survey process is already stressful
for facility staff and this will only be
made worse for employees who fear any
mistake could trigger a revisit and its
associated fee.
Response: If a problem has already
been corrected at the time of a standard
survey or complaint investigation, the
survey itself can confirm that the
correction has brought the provider or
supplier back into compliance with
federal requirements and the surveyor
would document such a determination.
In such a case no revisit would be
required unless the correction failed to
assure compliance. We appreciate that
PO 00000
Frm 00009
Fmt 4701
Sfmt 4700
53635
the survey process can be inherently
stressful for employees. We do not
believe, however, that the amount of the
revisit fee is so much as to add
measurably to the pre-existing stress
level for employees. The cost of a revisit
fee can be compared favorably to the
larger cost to beneficiaries from poor
quality of care, or to the larger financial
cost to providers from serious noncompliance with federal requirements,
such as civil monetary penalties or
termination of the provider agreement.
Only in the case of multiple revisits
would we expect the cumulative cost of
revisits fees to become a significant
expense for a particular provider. A
large number of revisits would occur
when there is a persistent pattern of
poor quality and documented inability
of a provider or supplier to sustain
compliance with federal requirements.
Such providers face more serious
consequences than revisit user fees. We
believe that the plain language of the
Continuing Resolution mandates that a
fee be collected whenever a revisit
occurs as a result of a deficiency found
during initial certification,
recertification, or substantiated
complaint surveys. Documentation
requirements supporting deficiency
citations are not being diminished,
eliminated or otherwise changed by this
proposed rule to create the scenario
raised by the commenter.
Comment: One commenter proposed
that onsite revisits be discretionary for
single ‘‘G’’ level deficiencies. Another
commenter indicated that it is unclear
what level deficiency would necessitate
a revisit. A few commenters believed
that oversight of correction of some
deficiencies could be done offsite and
requested clarification about when
onsite revisits are required.
Response: Our current policy requires
onsite revisits for condition level
citations. The current policy governing
revisit surveys is described in our
online state operations manual. We will,
however, consider policy issues raised
by several of the commenters for future
reconsideration. Some professional
discretion on the part of State survey
agencies will always be required. CMS
provides review and oversight of State
survey agencies through the CMS
regional offices. Our internal quality
assurance system provides for regional
office up-front input or subsequent
review when there is concern regarding
whether the revisit survey should be
conducted onsite or offsite. However we
have always maintained that a condition
level citation requires an onsite revisit
survey. ‘‘G’’ level deficiencies in
nursing homes are serious and are cited
only when one or more nursing home
E:\FR\FM\19SER2.SGM
19SER2
53636
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
jlentini on PROD1PC65 with RULES2
residents have been harmed. We will
continue to conduct revisits in such
circumstances.
2B. Survey Process: Hospitals, Home
Health Agencies, Hospices, Ambulatory
Surgical Centers, Rural Health Clinics,
and End-Stage Renal Disease Centers
Comment: One commenter felt that
although survey teams work off the
same worksheets, there is variation in
how different survey teams assess
similar situations. Therefore, the
commenter felt that requiring a ‘‘revisit’’
fee for all resurveys (either onsite or
offsite) will increase the number of
times that home health agencies will
contest the survey findings, which then
they may enter into an informal dispute
resolution process not only to avoid the
revisit fee but also to respond to the
issue of survey variation.
Response: CMS continuously works
with States to ensure that surveys are as
consistently applied as possible. CMS
also operates a national internal
consistency program in which
validation surveys are conducted by
Federal surveyors to promote optimum
consistency. It is possible that the revisit
user fees may have the ancillary effect
of increasing the extent to which
providers or suppliers dispute the
findings of surveys or complaint
investigations. We believe this may
occur whether the revisits are offsite or
onsite. We will monitor the effect of the
revisit fees to determine if any future
adjustments are advisable.
Comment: One commenter requested
clarification on whether user fees will
be imposed on accredited providers or
suppliers for a revisit following a
sample validation survey.
Response: We will not charge a fee for
a validation survey of a provider or
supplier that has been duly accredited
by a CMS-approved accrediting
organization and deemed to meet
Medicare requirements. While we
believe that a revisit fee pursuant to a
validation survey has basis, it is absent
in the language of the Continuing
Resolution. We would view this as
similar to a revisit survey conducted for
a non-accredited provider; we did not
however specify such a charge in the
proposed rule. We will therefore not
charge a revisit user fee in this final rule
for a revisit that follows a validation
survey, provided that the deemed status
of the provider or supplier has not been
removed by CMS. However, any survey,
including a validation survey, that finds
noncompliance with a Condition
(compared to just a Standard), typically
requires removal of deemed status and
a full survey of a provider. When an
accredited facility is found not to be in
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
substantial compliance with the
Medicare Conditions of Participation or
Conditions for Coverage, it must remain
under the jurisdiction of the State
Survey Agency until the State Survey
Agency verifies through revisits that the
facility has corrected its deficiencies
and demonstrated substantial
compliance. We believe in this case, the
removal of deemed status that initiated
with a validation survey, that then
remains under the jurisdiction of the
State survey agency is equivalent to any
other provider or supplier seeking
recertification. In this case a provider or
supplier cited for a deficiency during a
recertification survey that requires a
revisit survey would be assessed a
revisit user fee.
Comment: One commenter requested
clarification as to whether a full survey
following a substantiated complaint
survey in a deemed provider or supplier
is a revisit as defined in proposed
§ 488.30(a).
Response: A full survey that is
conducted pursuant to a complaint
investigation of an accredited facility
that has found condition-level
noncompliance is viewed as a revisit for
the purposes of the revisit fee. As
discussed in the response above,
noncompliance with a Federal
condition typically requires a removal
of deemed status and a full survey of a
provider. The purpose of this full survey
is two-fold: To verify correction of the
condition-level deficiencies identified
on the complaint investigation, and also
to confirm that the facility is in
substantial compliance with all of the
pertinent conditions for participation
before the State survey agency returns
jurisdiction over the facility to the
accreditation organization. Thus we
believe the activities of the survey fall
within the purposes of a revisit survey.
We appreciate all the comments
received regarding our current survey
process for all providers and suppliers.
CMS will maintain the current policy
process for the immediate future. We
will take all of these comments under
consideration as we continue to work
with States and our national consistency
program to provide continued oversight
and regulatory compliance guidance.
Section 488.30(b)—Criteria for
Determining the Fee
We proposed in § 488.30(b) to provide
the criteria for determining the user fee.
We proposed that for initial
implementation of revisit user fees, we
will use the criteria in proposed
§ 488.30(b)(1)(i) and (ii): That a provider
or supplier will be assessed a revisit
user fee based on the average cost per
revisit survey per provider or supplier
PO 00000
Frm 00010
Fmt 4701
Sfmt 4700
type and the type of the revisit survey
(onsite or offsite). If costs change
significantly in any future period for
which authority for the revisit user fee
exists, we would publish a Federal
Register notice providing a revised fee
schedule to the extent that fees may be
affected.
We also proposed that exceptions to
the assessment of a revisit user fee will
be identified based on the type of visit
conducted. For example, we proposed
that neither a provider nor a supplier
will be assessed a fee if the visit is
considered a ‘‘State monitoring visit’’
unless the visit also meets the definition
of a revisit, if the visit is to confirm
Medicare provider or supplier
compliance with Life Safety Code (LSC)
requirements, if the visit is to conduct
a Federal Monitoring Survey, such as a
Federal look-behind survey. See 72 FR
35677 (discussing ‘‘state monitoring
visit,’’ LSC, and Federal Monitoring
Surveys).
We also proposed in § 488.30(b)(1)(iii)
through (b)(1)(v) that CMS may adjust
revisit user fees to account for the
provider or supplier’s size, typically
determined by capacity (such as the
number of beds), the number of followup revisits resulting from uncorrected
deficiencies, and/or the seriousness and
number of deficiencies (such as the
scope and severity of cited deficiencies
and the number of deficiencies cited at
each scope and severity level), as these
criteria pertain to particular provider
types. Variance in provider/supplier
size, the number of follow-up revisits,
and the type and number of deficiencies
cited may have an impact on the survey
hours needed for a revisit. We also
proposed in § 488.30(b)(2) that CMS
may adjust the fees to account for any
regional differences in cost.
We received a variety of comments for
this section, the majority of which
discussed quality of care and the
concern that the user fee might cause
adverse incentives. We summarized all
of these comments and responded to
them under the general comments
section of this final rule. The comments
discussing the specific criteria proposed
in § 483.30(b) are provided below.
Comment: A few commenters stated
that additional information was needed
about how the various factors (for
example, a provider’s size, number of
revisits, scope and severity of
deficiencies) will impact the amount
being assessed. They asked whether
CMS would notify providers in advance
of the actual amount that would be
assessed, and whether providers would
be notified about how these factors were
specifically used to assess a given fee.
E:\FR\FM\19SER2.SGM
19SER2
jlentini on PROD1PC65 with RULES2
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
Response: We believe that the
adjustment criteria outlined in this
regulation can be important factors
affecting the number of survey hours
that would be required in a revisit
survey and therefore the cost of such
revisit survey. However, the final fee
schedule published in this rule does not
make use of all the potential factors that
might otherwise be used because we
believe many of the factors require more
analysis. Of the criteria listed in
488.30(b), CMS is only using
488.30(b)(1)(i) and (ii) for the immediate
future.
If Congressional authority for the
revisit fee is renewed or extended, and
CMS changes the overall methodology
for calculating and collecting these fees,
CMS will implement these changes
through notice and comment
rulemaking in the Federal Register. If
Congressional authority for the revisit
fee is renewed or extended but CMS
will not being implementing any
methodological changes, CMS will
publish proposed and final notices in
the Federal Register to announce and
solicit comment on planned updates,
adjustments, or changes to the criteria
used, if changes are to be made.
For example, CMS does not plan to
use criterion set forth at 488.30(b)(2)—
regional differences in cost—in the
immediate future. However, if CMS
should decide to use it in the future,
CMS will publish a notice in the
Federal Register announcing CMS’s
intention to do so, describing how CMS
intends to use and operationalize
488.30(b)(2), and to solicit public
comment. Similarly, for technical
adjustments or updates to the fee
schedule (e.g. adjustments for cost of
living increases), CMS will issue public
notices in the Federal Register.
On the other hand, if CMS should
decide in the future to use a completely
different criterion not described in these
rules, CMS will publish a notice of
proposed rulemaking announcing this
change in methodology.
Such future notices would address the
commenters’ concern regarding provider
or supplier size, for example, and how
the number of beds or the number of
patients or residents served might affect
a revisit fee.
In this final rule we do reserve the
right to adjust fees based on the number
of follow-up revisits conducted either
decreasing or increasing fees based on
the costs that are incurred by state
survey agencies to conduct these
multiple follow-ups. Any change to the
current fee schedule in which the same
revisit user fee is applied for each
revisit, will be preceded by Federal
Register notice of the planned change.
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
In this regulation we are providing the
information needed for each provider or
supplier to know the amount that they
would be charged if a revisit occurs.
These criteria incorporate the average
cost per provider or supplier for
conducting a revisit survey and the type
of revisit survey conducted (onsite or
offsite). We would charge the same fee
each time a revisit occurs, so if a revisit
revealed that the facility had not
achieved full compliance and if a
second revisit were required, the
provider would be charged the same
amount again for the second revisit.
Comment: One commenter suggested
that the fee should be based on the total
or estimated hours of service, not by the
actions performed during a survey.
Another commenter suggested that a
‘‘cap’’ be placed on the total amount of
user fees associated with a single revisit
and associated with a given provider.
One commenter acknowledged the
intent of the proposed change and
encouraged CMS to adjust revisit user
fees according to particularities of the
states, such as staff travel time, etc.
Response: We proposed in the June
29, 2007 Proposed Rule to use criteria
(b)(1)(i) (average cost per provider or
supplier type) and (b)(1)(ii) (revisit type:
Onsite or offsite), and have retained
those criteria in this final rule and fee
schedule. We agree with the commenter
that the fee should be based on the total
or estimated hours of service. We have
utilized an average cost per provider or
supplier based on the average costs per
hour for conducting revisit surveys. We
appreciate the comment regarding
suggesting a ‘‘cap’’ on the total amount
of fees associated with a single revisit.
We believe the methodology in this rule
conforms to the ‘‘cap’’ idea. As
discussed in the proposed rule,
providers or suppliers will be assessed
one fee per revisit. As discussed in the
Proposed Rule, when offsite preparation
is required, as it is in many cases, the
provider or supplier would not be
assessed a separate revisit fee for this
offsite preparation. Instead, the entire
preparation and actual onsite revisit
will count as an onsite revisit survey.
Based on current data analysis, CMS
proposed to implement the revisit user
fee utilizing only criteria identified in
§ 488.30(b)(1)(i) and (1)(ii). We
appreciate the commenters
encouragement to look at differences in
State costs for the revisits. In proposed
§ 488.30(b)(2) we reserved the right to
adjust the fees to account for regional
differences in costs. It is our intent to
conduct further analysis on these
additional criteria in proposing future
fee schedules. In this rule, the final fee
schedule is based on a simpler flat-rate
PO 00000
Frm 00011
Fmt 4701
Sfmt 4700
53637
methodology per provider type. If
regional cost differences were invoked
in any future change to the fee schedule,
we would publish a proposed and final
notice in advance of any such changes.
Comment: One commenter identified
that CMS, on July 17, 2007, stated that
certain provider types in California’s
Orange, Riverside, San Bernardino and
Los Angeles Counties would be under a
2 year demonstration to re-enroll in
Medicare, as well as be subject to a
survey should the provider have had a
Change of Ownership within the last 2
years. The commenter asked that
providers not be assessed a fee if the
visit is associated with this
demonstration.
Response: We agree with the
commenter and have specified that
neither a provider nor a supplier will be
assessed a fee if the visit is considered
a ‘‘State Monitoring visit’’ unless the
visit also meets the definition of a
revisit survey in this rule. In this case,
a Change of Ownership action, and
other actions involved in this particular
State demonstration, are considered a
‘‘State Monitoring visit’’ for purposes of
this final regulation and final fee
schedule. Therefore, providers and or
suppliers participating in the two year
demonstration would be exempt being
assessed a revisit user fee if the revisit
is associated with visits conducted
solely on behalf of this demonstration
and to the extent that they do not
involve deficiencies in compliance with
the Conditions of Participation or
Coverage.
We appreciate all of the commenters’
suggestions on our proposed criteria
sections, and have clarifications in
response to a number of the
commenters’ concerns. We intend to
provide the requested detail in
incorporating additional criteria when
calculating any changes to the fee
schedule for revisit user fees, if
authority is provided by the Congress
and through the notice and rulemaking
process described earlier. We believe we
have addressed concerns raised in this
section, therefore we will retain the
proposed language in § 483.30(b)(1) and
(b)(2) as final. We accordingly have
calculated the final fee schedule based
on selected criteria. The final fee
schedule will utilize criteria in
§ 488.30(b)(1)(i) and (b)(1)(ii) as
proposed and finalized by this rule.
Section 488.30(c)—Fee Schedule
We proposed in § 488.30(c) that CMS
will publish in the Federal Register the
proposed and final notices of a uniform
fee schedule before it adopts this
schedule. The proposed and final
notices would set forth the amounts of
E:\FR\FM\19SER2.SGM
19SER2
53638
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
the assessed fees based on the criteria as
identified in paragraph (b) of this
subpart. In future notices, any changes
to the amounts of the assessed fees
would include for example, adjustments
based on increases to cost of living,
labor and overhead costs. The proposed
rule also constituted publication of the
proposed fee schedule.
We based user fee calculations in the
proposed rule and fee schedule on the
type of revisit (onsite vs. offsite); the
type of provider or supplier; the average
number of hours that a revisit requires;
and the average per hour cost of a
revisit. We have identified the revisit
survey costs below under section IV,
Regulatory Impact Analysis.
We have received varying comments
raised under this section. The majority
of these comments referenced concerns
also raised under general comments, the
current survey process, and the criteria
for determining the fee. We believe we
have addressed these concerns in other
sections. Comments received on
§ 488.30(c) are below:
Comment: One commenter believed
that the Federal Register notice
contained a number of labels displaying
data regarding estimated costs and 2006
frequencies of revisit surveys, the
commenter felt that based on the
proposed language in Section 488.30(b)
that CMS intends to exercise
considerable latitude in the actual
levying of fees in a specific situation.
Another commenter felt that it is unfair
to providers to impose fees without
advance notification of the actual costs
based on any adjustment criteria.
Response: We will publish in the
Federal Register the proposed and final
notices of a uniform fee schedule before
we adopt this schedule. Both notices
would set forth the amounts of the
assessed fees based on the criteria as
identified in section 488.30(b). It will
also specify which of the criteria listed
in 488.30(b)(1)–(2) will be used and how
they will be operationalized.
In response to the nature of these
comments, we have clarified the
regulatory language and thus adopt as
final that § 488.30(c) will read: ‘‘CMS
must publish in the Federal Register the
proposed and final notices of a uniform
fee schedule before it assesses revisit
user fees. The notices must set forth
which criteria will be used and how, as
well as the amounts of the assessed fees
based on the criteria, as identified in
paragraph (b) of this subpart.’’ Language
placed in bold for emphasis on the
changes. We also note through the
publication of this final rule that if
authority for the revisit user fees is
continued, we will use the current fee
schedule in this rule for the assessment
of such fees until such time as a new fee
schedule notice is proposed and
published in final form.
The final fee schedule is identified
below in Table A. Summation of data
and calculations regarding this final fee
schedule is discussed in section V,
Regulatory Impact Analysis summary
below.
TABLE A.—FINAL FEE SCHEDULE FOR REVISITS SURVEYS
[Onsite and offsite]
Fee assessed
per offsite
revisit survey
Facility
SNF & NF ........................................................................................................................................................
Hospitals ..........................................................................................................................................................
HHA .................................................................................................................................................................
Hospice ............................................................................................................................................................
ASC ..................................................................................................................................................................
RHC .................................................................................................................................................................
ESRD ...............................................................................................................................................................
jlentini on PROD1PC65 with RULES2
Section 488.30(d)—Collection of Fees
1. § 488.30(d)(1)—Collection Methods
We proposed in § 488.30(d)(1) that
fees for revisit surveys under this
paragraph may be deducted from
amounts otherwise payable to the
provider or supplier. We also proposed
that fees will be deposited as an offset
collection to be used exclusively for
survey and certification activities
conducted by State survey agencies
pursuant to section 1864 of the Act or
by CMS, and will be available for CMS
until expended. We also proposed that
CMS may devise other collection
methods as it deems appropriate. In
determining these methods, CMS will
consider efficiency, effectiveness, and
convenience for the providers,
suppliers, and CMS. In the Proposed
Rule we stated that Methods may
include: Credit card; electronic fund
transfer; check; money order; and offset
of collections from claims submitted.
Comments: Several commenters
indicated that regarding the proposed
language that fees for revisits be
deducted from amounts otherwise
payable to the provider, they raised
concern that there were no specifics as
to whether these fees would be
deducted all at once or on a schedule.
Response: In the proposed language
CMS identified a number of methods for
the collection of the revisit user fee. For
the immediate future, we will utilize a
bill pay system. Providers or suppliers
who are assessed a fee will receive a
notice in the mail which will include
the amount of the assessed revisit fee
and the revisit survey for which the fee
is assessed. Included in the notice is the
obligation that payment is expected to
be remitted within 30 calendar days of
the date of the notice. As a means of
clarification and to expand on payment
methods that may be beneficial to
providers and suppliers and based on
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
PO 00000
Frm 00012
Fmt 4701
Sfmt 4700
$168
168
168
168
168
168
168
Fee assessed
per onsite
revisit survey
$2,072
2,554
1,613
1,736
1,669
851
1,490
the various comments, CMS will modify
the last sentence of § 488.30(d)(1) by
adding ‘‘any method allowed by law,
including credit card; electronic fund
transfer; check; money order; offset
collection from claims submitted.’’ We
will include all necessary details within
this coupon notice, including to whom
to direct questions, and payment
remittance information. In addition, as a
result of various comments regarding
the time frame for when we may collect
fees, and the concerns regarding the
schedule of these fees, we will include
an additional subparagraph
§ 488.30(d)(3) to this section that
indicates: ‘‘Fees for revisit surveys will
be due for any revisit surveys conducted
during the time period for which
authority to levy a revisit user fee
exists.’’
Comments: One commenter indicated
that they would prefer that if fees are
needed, then providers should be
charged an up-front fee that does count
E:\FR\FM\19SER2.SGM
19SER2
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
jlentini on PROD1PC65 with RULES2
towards approved expenses of doing
business/cost report based on bed size.
Response: The revisit user fees are
limited to fees for revisit surveys
conducted as a result of deficiencies
cited during an initial certification,
recertification and substantiated
complaint surveys. The fee will only be
applied when revisits are needed to
assure substantial compliance that
requirements are met. Although we
appreciate the commenters statement,
Congress’ clear intent was that CMS
assess a fee only for revisits required as
a result of deficiencies cited. It would be
out of the scope of our authority to
assess fees for upfront survey costs.
2. § 488.30(d)(2)—Cost Report
Comment: One commenter raised
concern regarding our statement: ‘‘At no
time is the individual provider’s cost
borne by other patients.’’ The
commenter felt our statement disregards
the nature of medical transactions and
that these revisit user fees, if extracted
from the provider’s income stream,
would directly impact the range and
quality of the services rendered by
competing on a cash basis with all other
spending priorities in the practice.
Response: Each revisit user fee will
arise from a provider’s documented
failure to comply with federal
requirements for quality of care or
safety. We hope that a provider would
not respond to a fee arising from such
failure by decreasing quality of care.
Such an action could simply give rise to
more quality compromises, more
complaints, more surveys or complaint
investigations, more revisits, and more
fees. The result would not make
economic or medical sense. We
appreciate the commenter’s concern that
a provider might respond to a revisit fee
by reducing services. This would
represent a business decision on the
part of the provider. An alternative
would be to invest in remedial action so
that quality would be improved and the
prospect of future revisits and revisit
fees would be reduced. We hope that
providers will adopt the alternative
approach.
Comment: Some commenters objected
to the fee, but stated that if the fee were
adopted then it should be considered an
allowable cost on the cost report. The
commenters expressed concern as to
where the funds would come from if the
fees were not permitted as an allowable
cost on the cost report, particularly, in
an industry already struggling to
continue to provide services.
Response: We proposed in
§ 488.30(d)(2) that fees for revisit
surveys under this section are not
allowable items on a cost report, as
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
identified in part 413, subpart B of this
chapter, under title XVIII of the Act. The
revisit user fee will be levied only as a
result of a provider’s failing to meet
basic quality of care or safety standards
that are required as a condition of
participation or coverage in the
Medicare program. As such, it is not
appropriate for a revisit user fee to be
an allowable item for a cost report. To
do so would lead to both cost-shifting
and the counterintuitive result that
more quality breakdowns could lead to
more payment. For these reasons, the
Secretary has put in place the necessary
mechanism for which cost-shifting
would be prevented. In addition, a
significant number of providers and
suppliers are reimbursed through the
prospective payment system; as a result,
only a small group of providers as
compared to the overall number of
providers and suppliers receive cost
based reimbursements.
While the user fee program is simply
intended to defray costs of the revisits,
we believe that the design of the user fee
program we finalize will result in a
positive correlation between quality of
care and amount of the fees—the better
the quality of care, the lower the fees.
We also expect that the prospect of fees
for revisits will promote greater
compliance with federal quality of care
requirements, thereby making for fewer
revisits and fewer fees over time.
Comment: A commenter stated that as
a result of the financial burden of the
revisit user fee, the expense for the
payment of this fee would be costshifted to private pay residents. The
commenter stated that, if the fee were to
be advanced this should include a
requirement that would ensure
increased Medicaid/Medicare
reimbursement to avoid shifting burden
of added costs to private-pay residents.
Another commenter felt that the fee
would also amount to a shifting of funds
and as a result either the money is
withheld from the hospital up front as
part of budget cuts or the hospital has
to pay it back as part of their CMS
certification process.
Response: We proposed in
§ 488.30(d)(2) that fees for revisit
surveys under this section are not
allowable items on a cost report, as
identified in part 413, subpart B of this
chapter, under title XVIII of the Act.
Part 413 identifies CMS’ formulating
methods for making fair and equitable
reimbursement for services rendered to
beneficiaries of the program. Payment is
to be made on the basis of current costs
of the individual provider, rather than
costs of a past period or a fixed
negotiated rate. This cost report also
designs this reimbursement formulation
PO 00000
Frm 00013
Fmt 4701
Sfmt 4700
53639
so that the individual provider’s costs
are not borne by other patients.
CMS believes that the assessed revisit
user fee is not an allowable item for a
cost report, as it should not be figured
into the services provided to
beneficiaries, nor should it be a cost
shared amongst non-Medicare patients.
CMS employs several checks and
balances to deter this from occurring.
CMS believes that this proposed
language in § 488.30(d)(2) would
prevent the inclusion of the revisit user
fee costs in any future cost reports. This
section will only apply to a small group
of providers who receive cost-based
reimbursement. A significant amount of
providers and suppliers are reimbursed
through the prospective payment system
(PPS).
As a result of comments received to
§ 488.20(d)(1) and (d)(2) and CMS’
further consideration, we will modify
the proposed language of § 488.30(d)(1)
and retain the proposed language of
§ 488.30(d)(2) as final. The proposed last
sentence of § 488.30(d)(1) will be
modified to read: ‘‘Any method allowed
by law, including credit card; electronic
fund transfer; check; money order; offset
collection from claims submitted.’’ The
remainder of the proposed language will
be retained as final.
Section 488.30(e)—Reconsideration
Process for Revisit User Fees
We proposed in § 488.30(e) that a
reconsideration process shall be
available to providers or suppliers that
have been assessed a revisit user fee if
a provider or supplier believes an error
of fact, such as a clerical error, has been
made. We also proposed that a request
for reconsideration must be received by
CMS within seven calendar days from
the date identified on the revisit user fee
assessment notice.
Comment: Several commenters
believe that a reconsideration process
should be available for surveyor errors
and substantial errors of interpretation,
and that it should not be limited to just
clerical errors. Another commenter
indicated that the reconsideration
process should include unfounded
citations. One commenter asked for
clarification on what was meant by
‘‘error of fact,’’ as a basis for requesting
a reconsideration. Another commenter
asked whether a provider could request
a reconsideration of a fee if they were
in the process of appealing deficiencies.
Response: The reconsideration
process for revisit user fees is intended
only for those situations in which a
provider or supplier believes that an
error of fact has been made in the
application of the revisit user fee. These
errors of fact would include such things
E:\FR\FM\19SER2.SGM
19SER2
jlentini on PROD1PC65 with RULES2
53640
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
as clerical errors, billing for a fee
already paid, inadvertent billing for a
revisit following a validation survey of
a deemed provider, or assessment of a
fee when there was no revisit
conducted. A request for
reconsideration of an assessed revisit
user fee is a separate process from any
informal dispute resolution or appeal of
the underlying deficiency citations.
Comment: Several commenters
thought that limiting the window for
revisit user fee reconsideration request
to seven calendar days was unrealistic
and requested that the timeframe for
reconsideration requests be expanded to
30 calendar days. Another commenter
requested that the timeframe for a
reconsideration request be extended to
10 calendar days, and other commenters
suggested a 14 or 15 calendar day
window. However, one commenter
thought that the seven day window was
reasonable.
Response: We proposed that a request
for reconsideration must be received by
CMS within seven calendar days from
the date identified on the revisit user fee
assessment notice. CMS has considered
the commenters’ suggestions for
extending the timeframe for submitting
a reconsideration request and we have
agreed to expand the timeframe for
reconsideration requests to 14 calendar
days from the date identified on the
revisit user fee assessment notice. We
will, therefore, change the timeframe for
submitting a reconsideration request to
14 calendar days in the final rule. The
time trigger date is the date when the
assessment notice is prepared and sent.
The revisit survey must have occurred
prior to our assessment of a revisit user
fee.
Comment: Several commenters
suggested that, where a reconsideration
determines that a revisit user fee was
charged in error, any payments made
should be refunded immediately,
instead of applying the payment to
future assessments of fees. One
commenter suggested that refunds
should be made within 30 days,
whereas another commenter suggested
60 calendar days of approval of a
reconsideration request. Commenters
thought that actions related to fees
should remain pending until the
outcome of the reconsideration, and that
a fee should not be paid until a facility
exhausts its appeals; upon successful
reconsideration, a provider would
receive written confirmation that a fee is
null and void.
Response: We believe that given the
proposed timeframe for submitting a
reconsideration request and the
regulatory obligation of payment (within
30 calendar days), there would be a
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
limited possibility that payment would
be sent without CMS providing a
response to the reconsideration. We,
however, believe that regulatory
clarification is warranted based on the
type of comments received. We have
modified the proposed text to include
separate subparagraphs § 488.30(e)(1)(i)
and (ii), (e)(2), and (e)(3). The modified
language of § 488.30(e) will read as
follows:
(e) Reconsideration process for revisit user
fees.
(1) CMS will review a request for
reconsideration of an assessed revisit user
fee—
(i) If a provider or supplier believes an
error of fact has been made in the application
of the revisit user fee, such as clerical errors,
billing for a fee already paid, or assessment
of a fee when there was no revisit conducted,
and
(ii) If the request for reconsideration is
received by CMS within 14 calendar days
from the date identified on the revisit user
fee assessment notice.
(2) CMS will issue a credit toward any
future revisit surveys conducted, if the
provider or supplier has remitted an assessed
revisit user fee and for which a
reconsideration request is found in favor of
the provider or supplier. If in the event that
CMS judges that a significant amount of time
has elapsed before such a credit is used, CMS
will refund the assessed revisit user fee
amount paid to the provider or supplier.
(3) CMS will not reconsider the assessment
of revisit user fees that request
reconsideration of the survey findings or
deficiency citations that may have given rise
to the revisit, the revisit findings, the need
for the revisit itself, or other similarly
identified basis for the assessment of the
revisit user fee.
We believe that the potential that a
provider or supplier would be assessed
a revisit user fee due to clerical error
would be rare, when this is viewed
through the overall survey process and
checks and balances inherent in the
survey and certification process. We
believe that in the rare case that this
assessment should occur, we have
provided providers and suppliers with
an opportunity to request a
reconsideration. We, indicated,
however, in § 488.30(e)(3) that ‘‘we will
not reconsider the assessment of revisit
user fees that request reconsideration of
the survey findings or deficiency
citations that may have given rise to the
revisit, the revisit findings, the need for
the revisit itself, or other similarly
identified basis for the assessment of the
revisit user fee.’’ We also, based on
comments received, have provided
providers and suppliers a greater
window for submission of requests for
reconsideration from 7 calendar days to
14 calendar days. We are including
additional language in § 488.30(e)(2)
PO 00000
Frm 00014
Fmt 4701
Sfmt 4700
that identifies that we will issue a credit
toward any future revisit surveys
conducted if a provider or supplier has
remitted an assessed revisit user fee and
for which a reconsideration request is
found in favor of the provider or
supplier as we discussed in the
preamble text of the Proposed Rule. We
further clarify that we ‘‘in the event that
CMS judges that a significant amount of
time has elapsed before such a credit is
used, CMS will refund the assessed
revisit user fee amount paid to the
provider or supplier.’’ In regards to the
commenters’ specific suggestion that
refunds should be made within 30
calendar days, or commenters that
suggested 60 calendar days, CMS will
make a concerted effort to respond to
requests for reconsideration within a
timely manner and notify providers or
suppliers that the reconsideration was
determined in their favor, as applicable
prior to the time frame for which they
must remit payment. However, in those
cases where remittance has occurred
and the provider or supplier has not
experienced an additional revisit survey
and is then due a refund, CMS is
committed to developing a system that
would ensure efficient refund of any
monies collected in error. CMS’ present
bill pay system would require more than
30 to 60 calendar day processes. We
estimate that this cause for a refund may
occur in less than 5% of all overall
cases. At this time, CMS does not have
the requisite data in which to provide
specific amounts of provider or
suppliers falling into this category,
however we believe it will be an even
lower percentage provided all the
inherent checks and balances in our
current survey and certification process.
Comment: Several commenters
requested that CMS clarify the time
frame for when a reconsideration
decision will be made, and one
commenter requested that CMS include
a deadline in the regulation for
responding to reconsideration requests.
One commenter proposed that
reconsiderations be resolved within 30
days of a reconsideration request.
Response: CMS is cognizant of the
providers’ 30 calendar day time frame
for submitting payment and will ensure
that reconsiderations are resolved in a
timely manner. CMS will make a
concerted effort to respond to request
for reconsideration within a timely
manner and notify provider or suppliers
that the reconsideration was determined
in their favor, prior to the time frame for
which they must remit payment.
We appreciate comments received on
time frames, refund methodology, and
notification. As a result of suggestions,
we have modified § 488.30(e) to include
E:\FR\FM\19SER2.SGM
19SER2
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
jlentini on PROD1PC65 with RULES2
within 14 calendar days for requests for
reconsideration. Section 488.30(e) will
read in final as discussed above.
Section 488.30(f)—Enforcement
We proposed in § 488.30(f) that if the
full revisit user fee payment is not
received within 30 calendar days or a
request for reconsideration is not
received within seven calendar days
from the date the provider or supplier
receives written notice of assessment,
CMS may terminate the facility’s
provider agreement and enrollment in
the Medicare program or the supplier’s
enrollment and participation in the
Medicare program, and the provider or
supplier may not seek Medicare
payment, nor be considered a Medicare
participating provider or supplier. We
have changed the seven calendar day
time period for filing of a
reconsideration request to fourteen
calendar days. Otherwise, CMS will
adhere to the termination process as
identified in § 489, subpart E, of this
chapter.
Comment: Some commenters
connected the discussion of revocation
of billing and the termination for
nonpayment as proposed in § 488.30(f)
and § 489.53(a)(16). One commenter felt
that termination for nonpayment within
30 days is power disproportionate to the
offense and is unrelated to quality of
care and safety issues. Another
commenter felt that this provision is
reason not to participate in Medicare, or
to care for Medicare patients.
Response: While we proposed that a
provider or supplier may also be
determined not to be in compliance if a
revisit user fee payment has not been
received within 30 calendar days from
the date identified on the assessment
notice, we also state at § 424.535(a)(1)
that all providers and suppliers are
granted an opportunity to correct the
deficient payment compliance before a
final determination is made to revoke
billing and enrollment privileges. We
further note that a payment-due notice
from CMS is preceded by a survey or
complaint investigation that has found
deficiencies, a correction period
afforded to the provider or supplier, a
revisit to confirm compliance, then a
later issuance of the payment-due
notice, followed by the formal 30-day
advance notice to the provider. As soon
as a revisit occurs, each provider or
supplier will know that a revisit user fee
will follow at a later date, will know the
amount of the fee due from the fee
schedule published in this rule, and
will know that the payment will be due
within 30 calendar days. While the rule
specifies that enforcement action may
occur if the bill has not been paid
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
within 30 calendar days, the total
amount of planning time available to the
provider or supplier will have totaled
much more than the 30-calendar day
period before any enforcement action
may occur. Finally, the revocation of
billing and enrollment privileges is not
an immediate action upon the failure of
a provider or supplier to remit the
assessed revisit user fee. In this final
rule we therefore retain the time-frames
for which action will occur regarding
this process and retain the amended
language to § 424.535(a)(1) as final.
Comment: A commenter indicated
that the definition of revisit survey
should be revised to limit it to those
revisits in which the cited deficiency
includes and is subject to an
enforcement action under Subpart B of
Part 489.
Response: We have not included the
commenter’s suggestion to revise the
term revisit survey to include ‘‘is subject
to an enforcement action under subpart
B of Part 489.’’ Subpart B of part 489
governs provider agreements, not
enforcement actions. However, we do
agree with the premise of the
commenter’s suggestion and thus have
modified language in § 488.30(f) to
include cross references to the
appropriate subpart and subsection of
part 489 (governing termination) and to
a subsection of part 424 (governing
revocation of enrollment and billing
privileges).
Section 488.30(f) will be modified to
read as applicable components
‘‘pursuant to § 489.53(a)(16) of this
chapter’’ and ‘‘pursuant to
§ 424.535(a)(1) of this chapter.’’ We
retain the remainder of the proposed
language in § 488.30(f) as final.
Part 489—Provider Agreements and
Supplier Approval
Subpart B—Essentials of Provider
Agreements
Section 489.20
Basic Commitments
Section 489.20(u)
We proposed to add to § 489.20 an
additional paragraph that would require
a provider to agree to pay revisit user
fees when and if assessed.
We did not receive comments
regarding this additional paragraph.
However, due to technical changes,
paragraph (u) is designated as paragraph
(w) and we will retain the proposed
language as final.
PO 00000
Frm 00015
Fmt 4701
Sfmt 4700
53641
Subpart E—Termination of Agreement
and Reinstatement After Termination
Section 489.53
Termination by CMS
Section 489.53(a)(16)
We proposed to add a new paragraph
(16) to § 489.53(a) that would create an
additional basis for termination if a
provider has failed to pay a revisit user
fee when and if assessed.
We did not receive comments
regarding this additional paragraph and
thus we retain the proposed language in
§ 489.53(a)(16) as final.
III. Provisions of the Final Rule
In this final rule we are adopting the
provisions as set forth in the June 29,
2007 proposed rule with the following
revisions:
All additional language proposed in
§ 424.535, Revocation of enrollment and
billing privileges in the Medicare
Program will be retained as final.
All proposed definitions in
§ 488.30(a) are adopted as final, except
for an addition to the definition of
‘‘provider of services, provider or
supplier.’’ The final definition now
includes religious nonmedical health
care institutions.
All proposed language in
§ 488.30(b)(1) and (b)(2) criteria for
determining the fee is adopted as final.
Language proposed in § 488.30(c) Fee
schedule is modified by removing term
‘‘will’’ and inserting the term ‘‘must’’
where applicable, we also removed
‘‘adopts this schedule’’ and added
‘‘assesses revisit user fees’’ for
clarification. In addition we include that
the clarifying language ‘‘which criteria
will be used and how, as well as
* * *,’’ the remainder of the language is
adopted as final.
The last sentence of the language
proposed in § 488.30(d)(1) has been
modified for clarification to state that
‘‘CMS may consider any method
allowed by law, including: Credit care;
electronic fund transfer; check; money
order; and offset collections from claims
submitted, the remainder of this
paragraph is retained as final. All
proposed language in § 488.30(d)(2)—
the prohibition of inclusion of the
revisit user fee on a provider cost
report—is adopted as final. We have
added a new subparagraph and new
language as a result of various
comments regarding the time frame for
when we may collect fees, and the
concerns regarding the schedule of these
fees, § 488.30(d)(3) will read: ‘‘Fees for
revisit surveys will be due for any
revisit surveys conducted during the
time period for which authority to levy
a revisit user fee exists.’’
E:\FR\FM\19SER2.SGM
19SER2
53642
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
Language proposed in § 488.30(e)
reconsideration process for revisit user
fees will be modified by changing the
formatting of the paragraph to include
paragraphs (e)(1)(i), (e)(1)(ii), (e)(2), and
(e)(3). Language in paragraph (e)(1)(i)
previously proposed as first sentence in
paragraph (e) is retained as final. We
have modified paragraph (e)(1)(ii) by
changing that a request for
reconsideration must be received by
CMS within 14 calendar days instead of
the 7 calendar days as proposed. We
have added a new paragraph (e)(2) that
identifies when CMS will issue a credit
or a refund of an assessed revisit user
fee in the rare case of a provider or
supplier remitting payment and
ultimately a reconsideration is decided
within their favor. We have added a
new paragraph (e)(3) that identifies that
a request for reconsideration of the
revisit user fee may not include
reconsideration of the survey findings or
deficiency citations that may have given
rise to the revisit, the revisit findings, or
the need for the revisit itself.
All proposed language in § 488.30(f)
Enforcement is adopted as final with the
addition of language identifying the
interconnection of changes made to both
§§ 424.535(a)(1) and 489.53(a)(16). The
language will read in final: ‘‘If the full
revisit user fee payment is not received
within 30 calendar days from the date
identified on the revisit user fee
assessment notice, CMS may terminate
the facility’s provider agreement
(pursuant to § 489.53(a)(16) of this
chapter) and enrollment in the Medicare
program or the supplier’s enrollment
and participation in the Medicare
program (pursuant to § 424.535(a)(1) of
this chapter).
All proposed new paragraphs to
§ 489.20 and § 489.53 are adopted as
final.
jlentini on PROD1PC65 with RULES2
Waiver of 30-Day Delay in the Effective
Date
We ordinarily provide a 30-day delay
in the effective date of the provisions of
a rule in accordance with the
Administrative Procedure Act (APA) 5
U.S.C. 553(d). However, the delay in the
effective date may be waived as, in
pertinent part, ‘‘provided by the agency
for good cause found and published
with the rule’’ 5 U.S.C. 553(d)(3). The
Secretary finds that good cause exists to
make effective the revisit user fee and
the corresponding fee schedule
immediately upon display and
publication in the Federal Register.
The good cause exception to the 30
day effective date delay provision of
section 553(d) of the APA is read to be
broader than the good cause exception
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
to the notice and comment provision of
section 553(b) of the APA.
The legislative history of the APA
indicates that the purpose for deferring
the effectiveness of a rule under section
553(d) was to ‘‘afford persons affected a
reasonable time to prepare for the
effective date of a rule or rules or to take
other action which the issuance may
prompt.’’ S. Rep. No. 752, 79th Cong.,
1st Sess. 15 (1946); H.R. Rep. No. 1980,
79th Cong., 2d Sess. 25 (1946). In this
case, affected parties do not need time
to adjust their behavior before this rule
takes effect. With or without a revisit
fee, a provider or supplier must be
found to have corrected significant
deficiencies in order to avoid
termination. Additionally, the
application of a fee for the revisit does
not place appreciable administrative
burdens on the affected providers or
suppliers. We do not expect appreciable
cost to State survey agencies because
CMS is undertaking the billing and
collection of the revisit user fee.
CMS identified in the proposed rule
the immediacy of this revisit user fee
program and the limited nature of the
Continuing Resolution. Specifically, the
Continuing Resolution requires CMS to
implement the revisit fee program in
fiscal year 2007. Accordingly, providers
and suppliers have been on notice for
some time that these fees would be
imposed, and do not need additional
time to be prepared to comply with the
requirements of this regulation. We
believe that given the short time frame
that CMS has to collect fees before the
authority of the Continuing Resolution
expires, there is good cause to waive the
30 day effective date.
IV. Collection of Information
Requirements
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995.
V. Regulatory Impact Analysis
A. Overall Impact
We have examined the impacts of this
rule as required by Executive Order
12866 (September 1993, Regulatory
Planning and Review), the Regulatory
Flexibility Act (RFA) (September 19,
1980, Pub. L. 96–354), section 1102(b) of
the Social Security Act, the Unfunded
Mandates Reform Act of 1995 (Pub. L.
104–4), and Executive Order 13132.
Executive Order 12866 (as amended
by Executive Order 13258, which
merely reassigns responsibility of
PO 00000
Frm 00016
Fmt 4701
Sfmt 4700
duties) directs agencies to assess all
costs and benefits of available regulatory
alternatives and, if regulation is
necessary, to select regulatory
approaches that maximize net benefits
(including potential economic,
environmental, public health and safety
effects, distributive impacts, and
equity). A regulatory impact analysis
(RIA) must be prepared for major rules
with economically significant effects
($100 million or more in any 1 year).
This final rule is not a major rule. The
aggregate costs will total approximately
$37.3 million in any 1 year.
The RFA requires agencies to analyze
options for regulatory relief of small
businesses. For purposes of the RFA,
small entities include small businesses,
nonprofit organizations, and small
governmental jurisdictions. Individuals
and States are not included in the
definition of a small entity. Small
businesses are small entities, either by
nonprofit status or by having revenues
of $6.5 million to $31.9 million or less
in any 1 year for purposes of the RFA.
In the June 29, 2007 Federal Register,
CMS issued a proposed rule identifying
its limited information to separate and
identify specific providers and suppliers
that may be subject to a revisit user fee
by the requirements described for
purposes of the RFA. CMS also
identified its limited information on the
total revenues collected by provider or
supplier type. CMS does collect
information regarding Medicare and
Medicaid claims submitted, however
this would not provide the requisite
requirements for the RFA regarding total
revenues. CMS also identified that it
does collect National level information
which includes personal health care
expenditures and payments. Personal
health care as we discussed in the
proposed rule includes hospital care,
professional services, nursing and home
health care, all of which cover those
services provided by the provider and
suppliers who may be assessed a revisit
user fee.
Based on the information provided
within the proposed rule a few
commenters felt that the user fee would
add what they consider financial strains
on an already strained nursing home
industry, especially to stand alone, notfor-profits. Additionally, two
commenters stated that the economic
implication must be considered,
including the potential impact on wages
for employees within healthcare
facilities. Another commenter requested
that CMS in this section take into
account State differences, citing their
State’s increased costs for all their home
health and hospice providers, who are
subject to increased fees in general and
E:\FR\FM\19SER2.SGM
19SER2
jlentini on PROD1PC65 with RULES2
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
felt this user fee would
disproportionately impact these
providers in their State. Another
commenter felt that Home Health
Agencies have been adversely impacted
by stagnant and declining
reimbursement from both Medicare and
Medicaid in the past years.
CMS specified in the proposed rule
that the providers and suppliers that
may be assessed a revisit user fee fall
into the category of revenues collected
under personal health care funds. As
such CMS calculated that the overall
impact of the estimated $37.3 million
that will be assessed for revisit user fees
would only amount to 2.3 percent of the
$1,560.2 million personal health care
revenues collected and only 1.9 percent
of all national health care expenditures
of which personal health care
expenditures are included.
Although we do not deny that the
revisit user fee would require a payment
from a provider or supplier who is
assessed a fee due to the need for a
revisit survey, we do not believe it will
have such an economic impact that it
would create additional financial strains
on providers and suppliers. We believe
that many providers and suppliers will
pay no fees because they consistently
provide high quality care, have no
deficiencies identified through the
survey process, and therefore will
require no revisits. Thus, this rule will
have minimal financial impact on those
providers and suppliers. In addition, we
appreciate the commenters’ concern
regarding their specific State’s financial
situation.
For the immediate future, we have
calculated the user fee by provider type
and by average number of hours
required for a revisit survey. It is our
intent that we will consider other
criteria as identified in § 488.30(b),
which includes regional differences
when proposing and finalizing future
fee schedules. Based on our information
gathered, we have determined, and the
Secretary certifies, that this rule will not
have a significant impact on small
entities based on the overall effect on
revenues.
Section 1102(b) of the Act requires us
to prepare a regulatory impact analysis
if a rule may have a significant impact
on the operations of a substantial
number of small rural hospitals. This
analysis must conform to the provisions
of section 604 of the RFA. For purposes
of section 1102(b) of the Act, we define
a small rural hospital as a hospital that
is located outside of a Metropolitan
statistical Area (superseded by Core
Based Statistical Areas) and has fewer
than 100 beds. This final rule affects
those small rural hospitals that have
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
been cited for a deficiency based on
noncompliance with required
conditions of participation and for
which a revisit is needed to make sure
that the deficiency has been corrected.
Based on the information provided as
a requirement for Section 1102(b) of the
Act, some commenters raised concerns
that these fees will be very expensive for
various rural providers or suppliers, not
just rural hospitals, but also small rural
Home Health Agencies and long-term
care facilities in rural communities, and
that CMS could be affecting the
availability of care in rural areas. One
commenter asked why hospitals should
be exempt from the fee just because the
fee may have a significant impact on
them; while another commenter raised
what they identified as unfairness in the
frequency of surveys conducted
annually for long-term care facilities
versus 3 years for hospitals.
Hospitals are not exempt from the
revisit user fees. While hospitals are
surveyed less frequently than nursing
homes, hospitals are subject to CMS
complaint investigations similar to
nursing home complaint investigations
as well as other providers and suppliers.
CMS is statutorily obligated to conduct
a regulatory impact analysis for small
rural hospitals as part of its rule making
process. As such, we have reviewed
data affecting these rural hospitals, and
upon that review have determined that
of all hospitals identified, 285 revisits or
3.9 percent were conducted in rural
hospitals to ensure that deficiencies
identified were corrected. Based on the
effective time period of this proposed
rule, less than 3 percent of all hospitals
may in fact be assessed a revisit user fee
in this current fiscal year (FY 2007), we
estimate that less than 1 percent of rural
hospitals will be impacted by this rule.
The statutory analysis that is required
does not indicate that small rural
hospitals would be exempt from
regulatory requirements. Rather, it
requires only that the rule making
agency must determine the overall
financial impact on small rural
hospitals. We do not make a distinction
on the quality-of-care provided to
residents or patients by either urban or
rural location. Federal regulations call
for all residents and patients to receive
adequate care. The revisit user fee will
only be assessed as a result of
deficiencies cited with respect to
providers or suppliers not fully
complying with Federal requirements.
With regard to the survey frequency,
nursing homes are mandated by statute
to be certified annually, whereas CMS
policy calls for hospitals (both
accredited and non-accredited) to be
PO 00000
Frm 00017
Fmt 4701
Sfmt 4700
53643
certified or deemed certified on a 3 year
cycle.
In addition, we appreciate the
commenters’ concern regarding the
potential impact on various rural
communities. For the immediate future,
we have calculated the user fee by
provider type and by average number of
hours required for a revisit survey. It is
our intent that we will consider other
criteria as identified in § 488.30(b),
which includes regional differences and
facility size when proposing and
finalizing future fee schedules. Based on
our information gathered, we have
determined, and the Secretary certifies,
that this rule will not have a significant
impact on small rural hospitals.
Section 202 of the Unfunded
Mandates Reform Act of 1995 also
requires that agencies assess anticipated
costs and benefits before issuing any
rule whose mandates require spending
in any 1 year of $100 million in 1995
dollars, updated annually for inflation.
That threshold level is currently
approximately $120 million. This rule
will have no mandated effect on State,
local, or tribal governments and the
impact on the private sector is estimated
to be less than $120 million and will
only effect those Medicare providers or
suppliers for which a revisit user fee is
assessed based on the need to conduct
a revisit survey to ensure deficient
practices that were cited have been
corrected.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a
proposed rule (and subsequent final
rule) that imposes substantial direct
requirement costs on State and local
governments, preempts State law, or
otherwise has Federalism implications.
This final rule will not substantially
affect State or local governments. This
final rule establishes user fees for
providers and suppliers for which CMS
has identified deficient practices and
requires a revisit to assure that
corrections have been made. Therefore
we have determined that this final rule
will not have a significant affect on the
rights, roles, and responsibilities of
State or local governments.
B. Impact on Providers/Suppliers
The source of the data used to
estimate the number and cost of revisit
surveys is CMS’s Online Survey,
Certification and Reporting (OSCAR)
database. OSCAR is the repository of
information about CMS and State survey
agency survey actions. Data collected
include the dates of surveys, survey
findings, and the length of time that
surveyors spent conducting the survey.
State survey agencies record survey time
E:\FR\FM\19SER2.SGM
19SER2
53644
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
on the CMS–670 form. Data from the
CMS–670 form are entered into OSCAR
by the State survey agency. CMS
analyzed average survey time length
using actual data from FY 2006.
Based on information entered into
OSCAR, we proposed user fees in
accordance with the type of revisit
survey (onsite vs. offsite); the type of
provider or supplier; the average
number of hours that a revisit survey
requires; and the average per hour cost
of a revisit survey.
Overall Effect on Providers and
Suppliers
We estimate that there are potentially
47,804 providers and suppliers affected
by the revisit user fee, although we
expect only some of those providers will
be charged a revisit user fee in any one
particular year. We based this estimate
on FY 2006 actual data. Table B below
presents the key information. Of those
providers and suppliers, 34.8 percent
required and received a revisit survey in
FY 2006, including both onsite and
offsite revisits. As identified in the
proposed rule, providers and suppliers
that required a revisit survey ranged
widely across facility types from 87.9
percent for skilled nursing facilities
(‘‘SNFs’’)/nursing facilities (‘‘NFs’’) to
2.8 percent for ambulatory surgical
centers. We did not include transplant
centers in FY 2006 and 2007
calculations due to lack of available cost
and revisit data at this time. Transplant
centers will be newly surveyed
providers starting in FY 2008, and will
be subject to revisit fees at the hospital
rate.
TABLE B.—PERCENTAGE OF PROVIDERS/SUPPLIERS THAT HAD A REVISIT SURVEY FY 2006
Total
providers/
suppliers1
Total revisit
survey for FY
2006 (onsite &
offsite)
Number of
providers/ suppliers that required revisit
survey(onsite
& offsite)
Percent of
provider/ suppliers that required revisit
survey (onsite
& offsite)
SNF/NF 2 ..........................................................................................................
Hospitals3 .........................................................................................................
HHAs ................................................................................................................
Hospices ..........................................................................................................
ASC ..................................................................................................................
RHC .................................................................................................................
ESRD ...............................................................................................................
15,172
7,139
8,901
3,077
4,735
3,828
4,952
29,426
853
1,585
307
188
216
929
13,350
594
1,320
246
133
204
781
87.9
8.3
14.8
7.9
2.8
5.3
15.7
Total ..........................................................................................................
47,804
33,504
16,662
34.8
1 Online
jlentini on PROD1PC65 with RULES2
Survey, Certification and Reporting (OSCAR) database (via PDQ, Provider Summary Table), includes providers considered active at
any time in the fiscal year.
2 Total number does not include Medicaid-only Nursing Facilities.
3 Total includes accredited and non-accredited hospitals, as well as psychiatric hospitals, and critical access hospitals.
Comments: One commenter observed
that, in CMS’ impact analysis and fee
proposals, CMS chose to include critical
access hospitals in a single grouping
with all other hospitals, even though
section 1861(e) of the Social Security
Act states that the term hospital does
not include, unless the context
otherwise requires, a critical access
hospital (as defined in section
1861(mm)(1)). The commenter stated
that because critical access hospitals are
typically smaller and less complex
organizations than most other hospitals,
the context clearly does not require their
inclusion with hospitals in this analysis
and that it would seem that the average
length of an onsite revisit survey, and
the corresponding assessed fee, would
be less than that of other hospitals. CMS
should at least present the relevant data
on critical access hospitals.
Response: We included critical access
hospitals in our hospital average fee due
to their similar functions and surveying
process. We believe this issue raised by
commenters has merit which will
require further analysis and we will
consider looking at critical access
hospitals in future fee schedules as its
own distinct entities. We agree that
revisit time may be affected by many
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
factors in addition to size of the facility.
We have adopted a relatively
straightforward method of calculating
the user fee. If the Congress renews or
extends the authority to collect the
revisit user fee for any considerable time
period, we intend to build into the fee
schedule a means to take into account
facility size and location to the extent
that we find such factors make a
significant difference in the time and
actual cost of the revisits.
Frequency and Duration of Revisit
Surveys
There are many differences across
providers and suppliers in the
frequency and duration of revisit
surveys. Skilled nursing facilities/
nursing facilities accounted for 83
percent of total onsite revisit surveys
conducted in FY 2006 following the
identification of deficiencies from
standard surveys. Home health agencies
accounted for 6 percent of onsite revisit
surveys in FY 2006, while ESRDs and
hospitals accounted for 8 percent, 4
percent each. Hospice facilities,
ambulatory surgical centers, and rural
health clinics combined comprised the
remaining 3 percent of revisits. The
average length of an onsite revisit
PO 00000
Frm 00018
Fmt 4701
Sfmt 4700
survey varied from 7.6 hours for rural
health clinics to 22.8 hours for
hospitals. In comparison, offsite revisit
surveys conducted averaged one and a
half hours (1.5) across all providers and
suppliers.
Fee Schedule for Onsite Revisit Surveys
We will base the final fee schedule on
the average length of time required for
revisit surveys by provider or supplier
type in FY 2006. Averages were
calculated separately by type of
provider or supplier, and the hours for
revisit surveys were separated by either
standard health surveys, complaint
surveys, or offsite surveys. A cost of
$100 per hour was incurred in FY 2005,
which was the basis of the cost
estimates in the Continuing Resolution.
We project that the actual current cost
based on inflation factors and
processing expenses is $112 per hour
and we will use this projected cost in
setting the fee schedule. In order to
obtain this inflation factor, CMS utilized
FY 2005 annual expenditures derived
from CMS–435 form that captures a
State’s cumulative expenditures and
divided this by information obtained
from CMS–670 form that identifies
State’s workload hours or survey hours,
E:\FR\FM\19SER2.SGM
19SER2
53645
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
as discussed above. The product of this
calculation resulted in dollars per hour
or cost incurred for conducting surveys.
CMS then took this number and
multiplied this by a composite rate of
inflation that was obtained from
percentage change calculations
identified in annual and semi-annual
indexes prepared by the U.S.
Department of Labor’s Consumer Price
Index for Wage Earners and Clerical
Workers (CPI-W). See U.S. Department
of Labor, Bureau of Labor Statistics.
Summary of Annual and Semi-Annual
Indexes. ONLINE. 2007. Bureau of Labor
Statistics. Available: https://
www.bls.gov/ro3/fax_9125.htm [22 Feb
2007]. In our fee schedule, the $112
average cost per hour is then multiplied
by the average hours for the revisit
surveys to achieve the average fee cost
per onsite revisit survey as identified in
Table C below. For the present, we will
not adjust fees based on the length of
individual revisit surveys, but will
assess a flat fee per revisit survey, based
on provider or supplier type. We expect
these costs to increase annually to
incorporate economic changes, cost of
living increases, labor and overhead
costs expenses if authority for the revisit
fee is continued in the future.
All revisit user fees will be assessed
after publication of this final rule.
TABLE C.—REVISIT USER FEE ASSESSMENT BASED ON AVERAGE LENGTH OF ONSITE REVISIT SURVEYS*
Average
length of
onsite revisit
survey (hrs)
Facility
SNF/NF ....................................................................................................................................................................
Hospitals** ................................................................................................................................................................
HHA .........................................................................................................................................................................
Hospice ....................................................................................................................................................................
ASC ..........................................................................................................................................................................
RHC .........................................................................................................................................................................
ESRD .......................................................................................................................................................................
* This
18.5
22.8
14.4
15.5
14.9
7.6
13.3
Fee assessed
per revisit
survey
(hrs × $112)
$2,072
2,554
1,613
1,736
1,669
851
1,490
includes onsite revisit surveys according to both Standard Health Surveys and Complaint Surveys.
center revisits will be charged at the hospital rate.
** Transplant
Proposed Fee Schedule for Offsite
Revisit Surveys
For offsite revisit surveys, we expect
a revisit user fee of $168 assessed
regardless of provider or supplier type.
Based again on recorded survey time on
the CMS–670 form, it was assessed that
offsite revisit surveys on average take
one and a half hours (1.5) across all
providers and suppliers. We calculated
the base hourly fee of $112 multiplied
by an average of one and a half hours
to arrive at the $168 fee assessed per
offsite revisit survey.
All revisit user fees will be assessed
after publication of this final rule and
fee schedule.
Costs for All Revisit User Fees Assessed
We expect the combined costs for all
providers and suppliers for all revisit
surveys in FY 2007 to total
approximately $37.3 million, with
onsite revisit surveys amounting to
approximately $34.6 million and offsite
revisit surveys totaling approximately
$2.7 million. However, actual fees
assessed in FY 2007 will be much less
than this annual amount, since we will
not charge for revisits that occur prior
to publication of this final regulation.
The rule will take effect the date of
publication. In order to give maximum
consideration to the fiscal impact of the
rule that would occur if it were in force
for an entire year, we provide here both
annual and quarterly estimates of the
impact as listed below in Tables D and
E. If authority for the revisit user fees is
continued beyond FY 2007, we will use
the current fee schedule in this rule for
the assessment of fees until a new fee
schedule notice is proposed and
published as final.
In Table D below, we provide the
projected quarterly costs based on the
fee schedule of this final rule. We
expect the combined costs for all
providers and suppliers for all onsite
revisit surveys for one quarter to total
approximately $8.6 million. We first
utilized the total number of onsite
revisit surveys for FY 2006, took the
expected revisit user fees assessed per
revisits as calculated in Table B above
estimated by provider or supplier and
multiplied this number by the number
of onsite revisit surveys expected for
one quarter. We then totaled all
providers and suppliers to achieve the
total quarterly costs for all onsite revisit
surveys.
TABLE D.—ESTIMATED QUARTERLY COSTS FOR ONSITE REVISIT SURVEYS
Number of
onsite revisit
surveys
(FY 2006)
jlentini on PROD1PC65 with RULES2
Facility
Fee assessed
per onsite
revisit survey
(hrs × $112)
(See Table B)
Number of onsite revisit surveys est. for
quarter*
Total costs for
onsite revisit
surveys for
quarter
SNF & NF ........................................................................................................
Hospitals ..........................................................................................................
HHA .................................................................................................................
Hospice ............................................................................................................
ASC ..................................................................................................................
RHC .................................................................................................................
ESRD ...............................................................................................................
14,288
575
1,068
256
95
149
698
$2,072
2,554
1,613
1,736
1,669
851
1,490
3,572
144
267
64
24
37
175
$7,401,184
367,776
430,671
111,104
40,056
31,487
260,750
Total ..........................................................................................................
17,129
........................
4,283
8,643,028
*Total number of onsite revisit surveys divided by 4 and rounded up based on FY 2006 actual data.
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
PO 00000
Frm 00019
Fmt 4701
Sfmt 4700
E:\FR\FM\19SER2.SGM
19SER2
53646
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
We expect the combined costs for all
providers and suppliers for all offsite
revisit surveys to total $687,960 on a
quarterly basis. In Table E below, we
first estimated by provider or supplier
the number of offsite revisit surveys
expected for one quarter and multiplied
this number by the expected revisit user
fee of $168 per offsite revisit survey as
discussed above. We then totaled all
providers and suppliers to achieve the
total costs for all offsite revisit surveys
for one quarter.
TABLE E.—ESTIMATED QUARTERLY COSTS FOR OFFSITE REVISIT SURVEYS
Fee assessed
per offsite
revisit survey
($112 × 1.5
hrs)
Number of
offsite revisit
surveys
(FY 2006)
Facility
Number of
offsite revisit
surveys est.
for quarter*
Total costs for
offsite revisit
surveys for
quarter
SNF & NF ........................................................................................................
Hospitals ..........................................................................................................
HHA .................................................................................................................
Hospice ............................................................................................................
ASC ..................................................................................................................
RHC .................................................................................................................
ESRD ...............................................................................................................
15,138
278
517
51
93
67
231
$168
168
168
168
168
168
168
3,785
70
129
13
23
17
58
$635,880
11,760
21,672
2,184
3,864
2,856
9,744
Total ..........................................................................................................
16,375
........................
4,095
687,960
*Total number of offsite revisit surveys divided by 4 and rounded up based on FY 2006 actual data.
As shown in Table F below, we
provide the total costs expected had the
rule been in effect for an entire FY 2007,
as well as the costs we would expect to
offset in the final quarter of the fiscal
year if the rule were in effect for the
entire last quarter of FY 2007 or an
entire quarter in the future.
TABLE F.—TOTAL COSTS COMBINED FOR ALL REVISIT SURVEYS PER FISCAL YEAR & QUARTER
FY 2007
One quarter*
Onsite Revisit Surveys ............................................................................................................................................
Offsite Revisit Surveys ............................................................................................................................................
$34,565,760
2,751,000
$8,643,028
687,960
Total Costs All Revisits ....................................................................................................................................
37,316,760
9,330,988
jlentini on PROD1PC65 with RULES2
*One quarter’s costs are based on quarterly revisit surveys rounded up to the nearest whole number as shown in Tables D & E; multiplying
Table F last quarter numbers in column 2 by 4 would create a slightly larger cost than identified in FY 2007 column 1 above.
As discussed above, we have
excluded Medicaid-only facilities (such
as Intermediate Care Facilities for the
mentally Retarded (ICFs/MR)),
comprehensive outpatient rehabilitation
facilities, providers of outpatient
physical therapy or speech pathology
services, independent laboratories,
portable x-ray centers, physical
therapists in independent practice,
federally qualified health centers,
chiropractors, Religious nonmedical
health care institutions (RNHCIs) in all
proposed rate-setting calculations.
We also expect that the revisit user fee
will have some effect in motivating
providers and suppliers to improve
quality, or if quality problems do occur,
to ensure that quality lapses are
corrected more quickly than in the past.
Both of these positive effects would
result in fewer revisit surveys being
necessary. However, CMS does
acknowledge that the revisit user fee
may have a counter effect of prompting
long-term care facilities to engage in the
informal dispute resolution process to
dispute State survey agency decisions
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
more frequently in order to avoid the
assessment of a fee.
We received a wide variety of
comments on the discussion of the
impact of this rule on providers and
suppliers and we have summarized
these comments below.
1. Unfairness in Charging Same Fees
Comments: A commenter stated that it
is unfair to charge the same revisit fee,
regardless of the seriousness or number
of deficiencies.
Response: We appreciate the
commenters’ implicit suggestion that
the amount of the revisit fee should be
scaled to reflect differences in the
number and seriousness of the
deficiencies identified. This rule
provides the basis to take such factors
into greater account in the future. If the
Congress renews or extends the user fee
authority beyond FY 2007, we plan to
examine this idea in more depth and act
on it if it is determined to be feasible
and correlated well with actual revisit
cost. In the fee schedule in this final
rule we take some small steps in the
direction of acknowledging that more
PO 00000
Frm 00020
Fmt 4701
Sfmt 4700
deficiencies or deficiencies of greater
severity may take more revisit time.
Under the current design in this rule,
many providers will pay no fees because
they consistently provide high quality
care, have no deficiencies identified
through the survey process, and
therefore will require no revisits. Other
providers may require some revisits but
with minimal costs because the
deficiencies are not serious, and the
revisit may be accomplished through an
offsite revisit survey. We have
established a much lower fee for offsite
revisit surveys since actual costs to the
survey program for offsite revisit
surveys are much less than the costs for
onsite revisit surveys, and the user fee
is intended only to recoup average
actual costs. We believe we have
designed the user fee program to result
in a positive correlation between quality
of care and amount of the fees—the
better the quality of care, the lower the
fees. We also expect that the prospect of
fees for revisits will promote greater
compliance with federal quality of care
requirements, thereby making for fewer
revisits and fewer fees over time.
E:\FR\FM\19SER2.SGM
19SER2
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
2. Equalized Rate State
Comments: A few commenters noted
that North Dakota is an equalized rate
state, meaning that nursing homes
cannot charge a per diem rate for private
pay residents that exceed the per diem
rate that Medicaid pays. Revenues are
limited and funds could be better spent
to improve the quality of care.
Response: In North Dakota nursing
homes are the only Medicaid providers
mandated to have equalization of rates.
Equalization of rates means nursing
facilities are prohibited from charging
private paying residents more than the
rate set by Medicaid. Medicaid controls
and sets the rate for all nursing home
residents except the 5 percent
controlled by Medicare. The legislature
sets the rate equal to the equalization
rate. This final rule will only apply to
Medicare providers and suppliers and to
dually-participating nursing facilities.
3. Charges Should Not Be Based on
Averages
Comment: A commenter felt that,
rather than charging on an average fee
basis by provider type, the charges
should be based on the specific number
of hours required to do the onsite visit
and be based on the actual hourly salary
cost of the surveyor, plus limited
overhead. This would help ensure that
the fees will not exceed actual cost and
will be specific to the level of effort
involved in the visit.
Response: We disagree. CMS does use
a national average actual cost per hour
(surveyors salaries, associated
overheads and miscellaneous costs for
travel, office space and equipment
rentals, etc.) in calculating the average
hours and costs for each provider type;
Skilled Nursing Homes, HHA, Hospice,
etc. revisits. However, we use average
costs per provider type and do not
individualize the fee to the exact
number of revisit hours for any one
provider, since we judge such extremely
specific pricing to be so
administratively expensive at this point
in time that it would detract
significantly from the fiscal benefits of
the revisit user fee.
Comment: A few commenters argued
that fees should reflect the actual cost of
conducting each providers survey,
rather than being based on national
average costs for each type of provider.
Response: We recognize that there are
differences among States and among
particular facilities that lead to different
costs of conducting revisit surveys. At
this time, CMS has determined to charge
an average fee per provider type, but
will consider changing the fee schedule
in the future to account for differences
among particular providers.
4. Fees Are Excessive
Comment: A few commenters felt that
the size of the fee was excessive.
Response: The size of the revisit fee
is sufficient to cover the costs that state
survey agencies incur in conducting the
surveys. We do not believe that the
amount of the revisit user fee will be
very significant except for those
providers that have a persistent problem
sustaining compliance with federal
requirements and may have many
revisits as a result. CMS’s expectation is
that all providers remain in compliance
with federal regulations at all times.
These federal regulations establish
minimally acceptable standards. The
user fee will cover the costs that the
state agency incurs in ensuring that
violations of federal regulations have
been corrected. The correction of many
minor deficiencies can be evaluated by
an offsite revisit survey, which will
result in a nominal charge.
C. Final Fee Schedule
Fee assessed
per offsite
revisit survey
Facility
SNF & NF ................................................................................................................................................................
Hospitals ..................................................................................................................................................................
HHA .........................................................................................................................................................................
Hospice ....................................................................................................................................................................
ASC ..........................................................................................................................................................................
RHC .........................................................................................................................................................................
ESRD .......................................................................................................................................................................
jlentini on PROD1PC65 with RULES2
D. Alternatives Considered
The revisit user fee in the Continuing
Resolution addresses important resource
issues in the Medicare survey and
certification programming budget. To
implement this revisit user fee process,
CMS is required to promulgate a
proposed regulation and proposed fee
schedule. CMS has attempted through a
variety of methods to encourage ways of
providers and suppliers to improve
quality and thus decrease the need to
conduct revisit surveys for deficiencies
cited prior to the inclusion of a revisit
user fee included in the FY 2007
Continuing Resolution. CMS continues
to conduct outreach and educational
efforts, quality analysis studies, and
review of current regulatory
requirements to focus in on health and
safety measures. In its outreach efforts,
CMS staff continues to present at trade
association meetings representing home
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
health agencies, hospices, skilled
nursing facilities/nursing facilities, and
other large accreditation organizations.
CMS staff speaks to new developments
within survey and certification policy,
updating of regulations, and
expectations that CMS has for those
providing services to its Medicare
beneficiaries. CMS in its continued
outreach and educational efforts
surrounding health and safety
requirements regularly posts and shares
any modification of policies or program
on its CMS survey and certification Web
site and through its survey and
certification online course delivery
systems. See U.S. Centers for Medicare
& Medicaid Services. ‘‘Certification &
Compliance.’’ ONLINE. 2007. CMS.
Available: https://www.cms.hhs.gov/
SurveyCertificationEnforcement/
01_Overview.asp. CMS also devoted a
substantial part of the work of the
PO 00000
Frm 00021
53647
Fmt 4701
Sfmt 4700
Fee assessed
per onsite
revisit survey
$168
168
168
168
168
168
168
$2,072
2,554
1,613
1,736
1,669
851
1,490
Quality Improvement Organizations
(QIOs) to educate providers and
suppliers on best practices and
expectations for meeting Federal health
and safety requirements. Despite these
efforts, there continue to be many
providers and suppliers that fail to meet
Medicare conditions of participation,
conditions for coverage or requirements
and require revisit surveys to ensure
compliance with Federal quality of care
requirements. In addition, costs for
these revisits continue to increase. CMS
believes that the assessment of revisit
user fees, as directed in the Continuing
Resolution, is a piece of the larger
efforts to address health care providers
and suppliers that have failed to comply
with Federal quality of care
requirements.
In accordance with Executive Order
12866, this rule has been reviewed by
the Office of Management and Budget.
E:\FR\FM\19SER2.SGM
19SER2
53648
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
(42 U.S.C. 1302 and 1395(hh)); Pub.L. 110–
5, H.J. Res. 20, § 20615(b)(2007).
List of Subjects
42 CFR Part 424
Emergency medical services, Health
facilities, Health professions, Medicare,
Reporting and recordkeeping
requirements.
42 CFR Part 488
Administrative practice and
procedure, Health facilities, Medicare,
Reporting and recordkeeping
requirements.
42 CFR Part 489
Health facilities, Medicare, Reporting
and recordkeeping requirements.
I For the reasons set forth in the
preamble, the Centers for Medicare &
Medicaid Services amends 42 CFR
Chapter IV, parts 424, 488, and 489 as
set forth below:
PART 424—CONDITIONS FOR
MEDICARE PAYMENT
1. The authority citation for part 424
continues to read as follows:
I
Authority: Secs. 1102 and 1871 of the
Social Security Act, unless otherwise noted
(42 U.S.C. 1302 and 1395hh).
Subpart P—Requirements for
Establishing and Maintaining Medicare
Billing Privileges
2. Section 424.535 is amended by
revising paragraph (a)(1) introductory
text to read as follows:
I
§ 424.535 Revocation of enrollment and
billing privileges in the Medicare program.
jlentini on PROD1PC65 with RULES2
(a) * * *
(1) Noncompliance. The provider or
supplier is determined not to be in
compliance with the enrollment
requirements described in this section,
or in the enrollment application
applicable for its provider or supplier
type, and has not submitted a plan of
corrective action as outlined in part 488
of this chapter. The provider or supplier
may also be determined not to be in
compliance if it has failed to pay any
user fees as assessed under part 488 of
this chapter. All providers and suppliers
are granted an opportunity to correct the
deficient compliance requirement before
a final determination to revoke billing
privileges.
*
*
*
*
*
PART 488—SURVEY, CERTIFICATION,
AND ENFORCEMENT PROCEDURES
1. The authority citation for part 488
is revised to read as follows:
I
Authority: Secs. 1102 and 1871 of the
Social Security Act, unless otherwise noted
VerDate Aug<31>2005
17:37 Sep 18, 2007
Jkt 211001
Subpart A—General Provisions
2. Part 488, subpart A is amended by
adding a new § 488.30 to read as
follows:
I
§ 488.30 Revisit user fee for revisit
surveys.
(a) Definitions. As used in this
section, the following definitions apply:
Certification (both initial and
recertification) means those activities as
defined in § 488.1.
Complaint surveys means those
surveys conducted on the basis of a
substantial allegation of noncompliance,
as defined in § 488.1.
Provider of services, provider, or
supplier has the meaning defined in
§ 488.1, and ambulatory surgical
centers, transplant centers, and religious
nonmedical health care institutions
subject to § 416.2, § 482.70, and
§ 403.702 [C8] of this chapter,
respectively, will be subject to user fees
unless otherwise exempted.
Revisit survey means a survey
performed with respect to a provider or
supplier cited for deficiencies during an
initial certification, recertification, or
substantiated complaint survey and that
is designed to evaluate the extent to
which previously-cited deficiencies
have been corrected and the provider or
supplier is in substantial compliance
with applicable conditions of
participation, requirements, or
conditions for coverage. Revisit surveys
include both offsite and onsite review.
Substantiated complaint survey
means a complaint survey that results in
the proof or finding of noncompliance at
the time of the survey, a finding that
noncompliance was proven to exist, but
was corrected prior to the survey, and
includes any deficiency that is cited
during a complaint survey, whether or
not the cited deficiency was the original
subject of the complaint.
(b) Criteria for determining the fee.
(1) The provider or supplier will be
assessed a revisit user fee based upon
one or more of the following:
(i) The average cost per provider or
supplier type.
(ii) The type of revisit survey
conducted (onsite or offsite).
(iii) The size of the provider or
supplier.
(iv) The number of follow-up revisits
resulting from uncorrected deficiencies.
(v) The seriousness and number of
deficiencies.
(2) CMS may adjust the fees to
account for any regional differences in
cost.
PO 00000
Frm 00022
Fmt 4701
Sfmt 4700
(c) Fee schedule. CMS must publish
in the Federal Register the proposed
and final notices of a uniform fee
schedule before it assesses revised
revisit user fees. The notices must set
forth which criteria will be used and
how, as well as the amounts of the
assessed fees based on the criteria as
identified in paragraph (b) of this
subpart.
(d) Collection of fees.
(1) Fees for revisit surveys under this
section may be deducted from amounts
otherwise payable to the provider or
supplier. As they are collected, fees will
be deposited as an offset collection to be
used exclusively for survey and
certification activities conducted by
State survey agencies pursuant to
section 1864 of the Act or by CMS, and
will be available for CMS until
expended. CMS may devise other
collection methods as it deems
appropriate. In determining these
methods, CMS will consider efficiency,
effectiveness, and convenience for the
providers, suppliers, and CMS. CMS
may consider any method allowed by
law, including: Credit card; electronic
fund transfer; check; money order; and
offset collections from claims submitted.
(2) Fees for revisit surveys under this
section are not allowable items on a cost
report, as identified in part 413, subpart
B of this chapter, under title XVIII of the
Act.
(3) Fees for revisit surveys will be due
for any revisit surveys conducted during
the time period for which authority to
levy a revisit user fee exists.
(e) Reconsideration process for revisit
user fees.
(1) CMS will review a request for
reconsideration of an assessed revisit
user fee—
(i) If a provider or supplier believes an
error of fact has been made in the
application of the revisit user fee, such
as clerical errors, billing for a fee
already paid, or assessment of a fee
when there was no revisit conducted,
and
(ii) If the request for reconsideration
is received by CMS within 14 calendar
days from the date identified on the
revisit user fee assessment notice.
(2) CMS will issue a credit toward any
future revisit surveys conducted, if the
provider or supplier has remitted an
assessed revisit user fee and for which
a reconsideration request is found in
favor of the provider or supplier. If in
the event that CMS judges that a
significant amount of time has elapsed
before such a credit is used, CMS will
refund the assessed revisit user fee
amount paid to the provider or supplier.
(3) CMS will not reconsider the
assessment of revisit user fees that
E:\FR\FM\19SER2.SGM
19SER2
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Rules and Regulations
request reconsideration of the survey
findings or deficiency citations that may
have given rise to the revisit, the revisit
findings, the need for the revisit itself,
or other similarly identified basis for the
assessment of the revisit user fee.
(f) Enforcement. If the full revisit user
fee payment is not received within 30
calendar days from the date identified
on the revisit user fee assessment notice,
CMS may terminate the facility’s
provider agreement (pursuant to
§ 489.53(a)(16) of this chapter) and
enrollment in the Medicare program or
the supplier’s enrollment and
participation in the Medicare program
(pursuant to § 424.535(a)(1) of this
chapter).
PART 489—PROVIDER AGREEMENTS
AND SUPPLIER APPROVAL
3. The authority citation for part 489
continues to read as follows:
jlentini on PROD1PC65 with RULES2
I
VerDate Aug<31>2005
18:10 Sep 18, 2007
Jkt 211001
Authority: Secs. 1102, 1819, 1861,
1864(m), 1866, 1869, and 1871 of the Social
Security Act, 42 U.S.C. 1302, 1395i–3, 1395x,
1395aa(m), 1395cc, 1395ff, and 1395hh).
Subpart B—Essentials of Provider
Agreements
4. Section 489.20 is amended by
adding a new paragraph (w) to read as
follows:
I
§ 489.20
Basic commitments.
*
*
*
*
*
(w) To comply with § 488.30 of this
chapter, to pay revisit user fees when
and if assessed.
5. Section 489.53 is amended by
adding a new paragraph (a)(16) to read
as follows:
I
(16) It has failed to pay a revisit user
fee when and if assessed.
*
*
*
*
*
(Catalog of Federal Domestic Assistance
Program No. 93.778, Medical Assistance
Program) (Catalog of Federal Domestic
Assistance Program No. 93.773, Medicare—
Hospital Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: September 7, 2007.
Kerry Weems,
Acting Administrator, Centers for Medicare
& Medicaid Services.
Approved: September 12, 2007.
Michael O. Leavitt,
Secretary.
[FR Doc. E7–18458 Filed 9–18–07; 8:45 am]
BILLING CODE 4120–01–P
§ 489.53
Termination by CMS.
(a) * * *
PO 00000
Frm 00023
Fmt 4701
Sfmt 4700
53649
E:\FR\FM\19SER2.SGM
19SER2
Agencies
[Federal Register Volume 72, Number 181 (Wednesday, September 19, 2007)]
[Rules and Regulations]
[Pages 53628-53649]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-18458]
[[Page 53627]]
-----------------------------------------------------------------------
Part II
Department of Health and Human Services
-----------------------------------------------------------------------
Centers for Medicare & Medicaid Services
-----------------------------------------------------------------------
42 CFR Parts 424, 488, and 489
Establishment of Revisit User Fee Program for Medicare Survey and
Certification Activities; Final Rule
Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 /
Rules and Regulations
[[Page 53628]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Parts 424, 488, and 489
[CMS-2268-F]
RIN 0938-AO96
Establishment of Revisit User Fee Program for Medicare Survey and
Certification Activities
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This final rule will establish a system of revisit user fees
applicable to health care facilities that have been cited for
deficiencies during initial certification, recertification, or
substantiated complaint surveys and require a revisit to confirm that
corrections to previously-identified deficiencies have been remedied.
Consistent with the President's long-term goal to promote quality of
health care and to cut the deficit in half by fiscal year (FY) 2009,
the FY 2007 Department of Health and Human Services' (HHS) budget
request included both new mandatory savings proposals and a requirement
that user fees be applied to health care providers that have failed to
comply with Federal quality of care requirements. The ``Revisit User
Fees'' will affect only those providers or suppliers for which a
revisit is required to confirm that previously-identified failures to
meet federal quality of care requirements have been remedied. The fees
are estimated at $37.3 million annually and will recover the costs
associated with the Medicare Survey and Certification program's revisit
surveys. The fees will take effect on the date of publication of the
final rule and will be in effect until the date that the continued
authority provided by Congress expires. At the time of publication of
this regulation the applicable date is September 30, 2007. If no
legislation is enacted, the fees are not retroactive to the beginning
of the fiscal year. Any provider or supplier that has a revisit survey
conducted on or after the date of publication will be assessed a
revisit user fee and will be notified of the assessment upon data
system reconciliation which can occur following the closing of the
fiscal year. The fees will be available to CMS until expended. The
revisit user fee is included in the President's proposed FY 2008
budget. We note through the publication of this final rule that if
authority for the revisit user fee is continued, we will use the
current fee schedule in this rule for the assessment of such fees until
such time as a new fee schedule notice is proposed and published in
final form.
DATES: Effective Date: These regulations are effective on September 19,
2007.
FOR FURTHER INFORMATION CONTACT: Carla McGregor, (410) 786-0663
SUPPLEMENTARY INFORMATION:
Table of Contents
I. Background
A. Overview
In the June 29, 2007 Federal Register (72 FR 35673), we published
the proposed rule entitled, ``Establishment of Revisit User Fee Program
for Medicare Survey and Certification Activities'' and provided for a
60 day comment period. This rule sets forth final requirements and the
final Fee Schedule for providers and suppliers who require a revisit
survey as a result of deficiencies cited during an initial
certification, recertification, or substantiated complaint survey.
The Centers for Medicare & Medicaid Services (CMS) has in place an
outcome-oriented survey process that is designed to determine whether
existing Medicare-certified providers and suppliers or providers and
suppliers seeking initial Medicare certification are actually meeting
statutory and regulatory requirements, conditions of participation, or
conditions for coverage. These health and safety requirements apply to
the environments of care and the delivery of services to residents or
patients served by these facilities and agencies. The Secretary of the
Department of Health and Human Services (``HHS'') has designated CMS to
enforce the conditions of participation/coverage and other requirements
with these programs. The revisit user fee will be assessed for revisits
conducted in order to determine whether deficiencies cited as a result
of carrying out CMS's survey process obligations have been corrected.
B. Requirements for Issuance of Regulations
Section 20615(b) of The Continuing Appropriations Resolution
(``Continuing Resolution'') budget bill passed by the Congress and
signed by the President directed HHS to implement the revisit user fees
in FY 2007. Section 20615(b) states as follows:
The Secretary of Health and Human Services shall charge fees
necessary to cover the costs incurred under `Department of Health
and Human Services, Centers for Medicare and Medicaid Services,
Program Management' for conducting revisit surveys on health care
facilities cited for deficiencies during initial certification,
recertification, or substantiated complaints surveys. Not
withstanding section 3302 of title 31, United States Code, receipts
from such fees shall be credited to such account as offsetting
collections, to remain available until expended for conducting such
surveys (Pub. L. 110-5, H.J.Res.20, Sec. 20615(b)(2007)).
As directed by the Secretary, in the June 29, 2007 Federal Register
(72 FR 35673), CMS established revisit user fees for revisit surveys
and put forth in regulation the definitions, criteria for determining
the fee, the fee schedule, collection of fees, reconsideration process
for revisit user fees, enforcement and regulatory language addressing
enrollment and billing privileges, and provider agreements. In the
proposed rule, cost projections were based on FY 2006 actual data and
were expected to amount to $37.3 million on an annual basis. These
calculations were included in section IV Regulatory Impact Analysis in
the proposed rule (72 FR 35678).
The fees will take effect on the date of publication of the final
rule and will be in effect until the date that the authority provided
by the Congress expires. At the time of publication of this regulation
the applicable date is September 30, 2007. As discussed thoroughly in
the proposed rule, based on the Congress' knowledge of section 1864(e)
of the Social Security Act and already established survey and
certification activities, the unambiguous nature of section 20615(b) of
the Continuing Resolution, and the principles of lex posterior derogate
legi priori or ``last-in-time'' rule, the Secretary has the authority
to implement this revisit user fee and establish a final fee schedule.
See 72 FR 35674-35675 (discussing section 1864(e) of the Social
Security Act).
II. Summary of the Proposed Provisions and Response to Comments
In the June 29, 2007 Federal Register (72 FR 35673), we published
the proposed rule entitled, ``Establishment of Revisit User Fee Program
for Medicare Survey and Certification Activities'' and provided for a
60 day comment period.
We received a total of 74 comments from various providers,
suppliers, health care associations, and individual health care
professionals and other individuals. The comments ranged from general
support of the survey process or general opposition to the proposed
provisions to very specific questions or comments regarding the
proposed new revisit user fee.
[[Page 53629]]
Brief summaries of each proposed provision, a summary of the public
comments we received and our responses to the comments are set forth
below. Comments related to the paperwork burden and the impact analyses
are addressed in the Collection of Information and the Regulatory
Impact Analysis sections in this preamble.
General Comments
1. Time Period for Levying Fees
Comment: Several commenters suggested that CMS should not allow
user fees for nursing home revisits beyond the end of the fiscal year.
The commenters believe that nursing homes bear the brunt of the overall
survey process because surveys are conducted annually for nursing homes
and as such CMS should ensure that the fee is not renewed.
Response: The President's HHS budget for FY 2007, as enacted by the
Congress, directs the HHS Secretary to implement the revisit user fees
during FY 2007. Since the provisions for the revisit user fee were put
forth through the annual appropriations process, continuation of the
fees under this regulation beyond September 30, 2007 will depend on
Congressional renewal or extension of the time period under which fees
may be assessed. While nursing homes have the most frequent surveys,
they also have the largest number of revisits. Revisits in nursing
homes represent the largest single source revisit costs. While there
would be cost to some--but not all--nursing homes as a result of the
revisit fees, nursing homes also benefit from being able to reassure
prospective nursing home residents and their families that the nursing
home is federally certified and that there is an objective and
independent system of oversight to assure quality. The revisit survey
is an essential element of that quality assurance system. We also note
that the revisit fees are not restricted to nursing homes, but apply to
almost all providers and suppliers that require a revisit to confirm
that identified deficiencies are remedied.
2. Authority to Assess a Revisit User Fee
Comment: A few commenters expressed concern that revisit fees would
be imposed when the authority granted to levy fees expires on September
30, 2007 and that there does not appear to be legislation pending that
would extend CMS' authority to impose these fees beyond FY 2007. One
commenter stated that if the Congress does not extend this authority,
then it appears that this rule will be void. Another commenter
disagrees with CMS interpretation of section 1864(e) of the Social
Security Act (the Act) as giving HHS the ``authority to assess revisit
user fees.'' The commenter felt that clearly the inclusion and specific
wording in this section within the Act indicates Congress intended that
the Secretary ``may not impose'' any fee on any facility for any survey
(revisit or otherwise) for determining compliance ``with any
requirement of this title.''
Response: We are frequently expected to implement legislation that
is promulgated by the Congress and therefore has the force of law, as
in the passed FY 2007 appropriations bill. We strive to implement the
provisions in an efficient and effective manner once it becomes law.
The commenter is correct that the current authority to impose the
revisit user fee expires for revisits occurring after September 30,
2007, unless otherwise authorized via legislation or through the FY
2008 appropriations bill, as examples. The revisit user fee is included
in the President's proposed FY 2008 budget. We acknowledge the
commenter's disagreement with the Congress' intent as it relates to
authority to impose any fee based on the Social Security Act. However,
as we discussed in the Proposed Rule, we believe that Congress intended
to give the Secretary authority to implement this revisit user fee
program when Congress enacted section 20615(b) of the Continuing
Resolution.
3. ``Good Performers Versus Poor Performers''
Comment: Several commenters believed that those nursing homes
considered to be providing excellent care would be required to pay a
revisit user fee along with nursing homes that are considered poor
performers. The commenters believe that even minor infractions
uncovered during an annual survey for these higher quality nursing
homes would still lead to the imposition of a revisit user fee. A
commenter questioned whether or not those facilities going above and
beyond to provide higher level care through higher costs of operations
should be subjected to this user fee in the same manner as those
facilities that are performing at the bare minimum requirements with
lower costs of operations if the goal is to promote a better health
care environment.
Response: We believe that many nursing homes will pay no revisit
user fees because they consistently provide high quality care, have no
deficiencies identified through the survey process, and therefore will
require no revisits. Other nursing homes may require some revisits but
with minimal costs because the deficiencies are not serious, and the
revisit may be accomplished through an offsite survey. We have
established a much lower fee for offsite surveys since actual costs to
the survey program for these revisit surveys are much less than the
costs for onsite surveys, and the user fee is intended only to recoup
average actual costs. We believe we have designed the user fee program
to result in a positive correlation between quality of care and amount
of the fees--the better the quality of care, the lower the fees. We
also expect that the prospect of fees for revisits will promote greater
compliance with federal quality of care requirements, thereby making
for fewer revisits and fewer fees over time.
4. Revisit User Fee Compared to Penalty
Comment: Several commenters believe the revisit user fee
constitutes a penalty regardless of whether cited deficiencies are
appealed and overturned. They also stated that the revisit user fee
imposed additional penalties that may be assessed.
Response: The revisit user fee does have some similarities to a
quality of care penalty in so far as the revisit user fee only applies
to providers or suppliers for which deficiencies have been identified.
There are differences, however, between the revisit user fee and
traditional penalties. For example, a traditional penalty, such as a
civil monetary penalty, is assessed according to the scope and severity
of individual deficiencies that have been identified. A penalty amount
would be independent of the cost for the time required by surveyors to
revisit the provider in order to confirm that corrections have been
made. In contrast, the revisit user fee is designed only to replace the
average actual cost associated with the revisits themselves. Second,
currently only nursing homes are subject to civil monetary penalties;
no other Medicare-certified providers or suppliers affected by this
regulation are subject to CMS CMPs for quality of care deficiencies at
this time. Among nursing homes, only approximately 12 percent of
nursing homes are levied a CMP in any particular year, on average. If a
revisit survey is required, a user fee will be assessed; however this
does not necessarily mean a CMP will be levied as well.
5. Revisit User Fee Compared to Taxes
Comment: One commenter stated that the revisit user fee amounted to
a new tax. Another commenter felt that the revisit user fee was an
example of extortion and that the funding to
[[Page 53630]]
administer the survey process including revisits is already in place.
They equated this fee to have the same effect as if the IRS was to
impose a fee when the individual's tax return is flagged for an audit.
A commenter felt the fee would amount to financial impropriety on the
part of the government.
Response: We believe that the commenter's characterization of the
revisit user fee as a ``tax'' is not accurate. Taxes are typically
imposed regardless of whether the taxed parties actually use the
services that the tax makes possible. Taxes must be paid regardless of
the extent of government services that are accessed. In contrast, the
revisit user fee will be levied only for those who fail to comply fully
with their responsibilities to provide quality care and to abide by
federal quality of care and related requirements under the Medicare
Provider Agreement and applicable regulations and laws for providers
and suppliers. Such failure obliges CMS to incur revisit survey costs
that would not otherwise have been incurred. The revisit user fee
amount is calibrated to match the additional resources required, on
average, for the surveyors to verify compliance with known federal
requirements subsequent to the provider's or supplier's initial failure
to meet those requirements fully.
6. Effects on Resident or Patient Care
Comment: Several commenters raised concern that the assessment and
payment of the user fee would remove several thousand dollars per
facility that otherwise would be available for resident care. Another
commenter felt the ethics of this proposal would adversely affect the
citizens of a State. The commenter felt that the revisit user fee was
unfair. Other commenters stated, in various ways, that the revisit user
fee would remove valuable resources that would otherwise be expended
for patient and employee resources. They felt that a direct drawdown
from funds used for patient care would occur, resulting in no
improvement to the quality of resident care. Finally, they felt that
there would be a direct adverse fiscal impact on smaller more
financially challenged facilities.
Response: CMS believes the providers and suppliers are the
controlling agents in managing the quality of care of services provided
in their healthcare facilities. Providers and suppliers may avoid
revisit fees by ensuring sustained compliance with federal quality of
care requirements. The revisit user fees simply compensate for the
costs of confirming that previously-identified problems have been
remedied. The certainty that a revisit will occur is a substantial
incentive for a provider to make the necessary corrections; therefore,
we believe that this quality assurance function will improve care and
safety for Medicare beneficiaries. In addition, we believe the
imposition of revisit user fees will likely encourage a sustained
commitment to management systems that improve quality of care provided
to all clients served by the provider. CMS does not believe that the
revisit user fee should harm quality of care provided, but can instead
become a valuable, additional incentive to encourage providers and
suppliers to commit to sustained compliance with federal quality of
care requirements. The quality of care message is that providers and
suppliers will have no user fees when quality of care meets the
appropriate federal standards. To the extent that there are
deficiencies, providers and suppliers will have only small fees to the
extent that the deficiencies are not serious or widespread. If quality
problems do occur, providers and suppliers will have greater incentives
to ensure that quality lapses are corrected more quickly than in the
past, since the revisit fees will be less if only one revisit is
required.
7. State Practices and Incentives for Revisits
Comment: Several commenters expressed a concern that State survey
teams would be instructed to find more violations if a revisit user fee
were in place, thus increasing the number of revisit surveys. One
commenter also raised the concern that the facility will have to pay a
revisit user fee for a revisit survey although the State may not
consider the deficiency severe. Another commenter raised concern that
there would be tremendous potential for abuse, that surveyors lacked
experience and that there existed too much financial control of the
facilities in the hand of the state surveyors. This commenter also
expressed concern as to whether there would be adequate monitoring of
State agencies for potential abuse of this program. Two commenters
believed the fee would increase the number of revisits currently being
done, putting an extra burden on staff as well as required additional
time for State surveyors. One commenter felt that the nursing home
revisits would increase to 100 percent because of what they consider a
financial incentive.
Response: We agree that any potential conflict of interest, and any
appearance of conflict of interest, must be addressed in the design and
operation of any user fee program. A number of safeguards will prevent
any such potential conflict from becoming a serious reality. First, the
revisit user fees will be collected nationally by CMS through a
contractor rather than by individual States. CMS makes allocations to
States based on the effects of inflation and on overall survey and
certification workload and performance for all survey and certification
functions, with revisits comprising just one of many functions. The
national survey and certification budget may not exceed the level
established by Congress, regardless of the level of revisit fee
collections. Second, all States must conduct revisits according to
policies and procedures established by CMS. Those policies and
procedures are publicly available in CMS' State Operations Manual (SOM)
and in numbered Survey & Certifications policy memoranda published on
the CMS Web site. Such policies and procedures define the circumstances
under which revisit surveys, both onsite and offsite, occur and when
they do not occur. CMS Regional Offices monitor State implementation of
the policies and procedures. We intend to increase CMS monitoring for
revisits. Third, States incur substantial costs in order to conduct
revisits. Such costs are not lightly undertaken, since there are
formidable natural and governmental constraints on a State survey
agency's ability to make use of any added funds that might conceivably
become available even if there were a direct fiscal connection between
revisits and the amount of money the State survey agency were to
receive. The single largest cost to a State survey agency, for example,
is personnel. The ability of a State survey agency to hire new staff
(even when new revenue becomes available) is either very limited or
there is a long delay between the availability of such funds and the
hiring of a surveyor. Once hired, the surveyor must typically undergo
about six months of training and observing before being entrusted to
conduct surveys. These constraints make it unlikely that a State survey
agency would incur the upfront staffing costs of conducting revisits
that were not required, or would seek to identify more deficiencies
simply to justify a revisit and hope that at some vague future date the
added costs might be recognized by CMS. To the extent that the revisit
user fee does create any type of new incentive, we expect that the main
incentive will be for providers and suppliers to maintain compliance
with federal quality of care and safety requirements, since such
compliance offers a clear pathway to the avoidance of revisit fees.
[[Page 53631]]
Comment: One commenter stated that the proposed rule would increase
fees for facilities that had follow-up for routine licensure/
certification surveys as well as complaint visits.
Response: Revisit user fees will apply only to surveys that occur
after an initial certification, recertification, or substantiated
complaint survey has identified deficiencies. State licensures issues
that a State survey agency might address during a survey or a revisit
survey are separate activities not connected with the assessment of a
revisit user fee. Surveyor time spent on State-only issues must also be
cost-accounted for by State survey agencies to ensure that such costs
are not billed to the federal government. Thus, a survey or revisit
survey based solely on State licensure requirements would not create
the assessment of a revisit user fee. Only the need to conduct revisit
surveys regarding Federal conditions of participation, requirements, or
conditions for coverage would trigger a revisit user fee.
Comment: One commenter observed that State and federal regulations
require nursing facilities to report allegations of abuse and other
issues to the State survey agency. The commenter expressed concern that
such mandatory reports will result in a visit from the Survey Agency
inspectors, usually without any finding of regulatory deficiencies. The
financial impact of the proposal could be very burdensome for many
nursing facilities.
Response: An initial visit to investigate a complaint, such as the
allegation of abuse and or neglect mentioned by the commenter would not
trigger a revisit user fee. A revisit would be required only if a
deficiency is identified as a result of that complaint investigation.
The user fee would not apply to the initial complaint investigation; it
would apply only to the revisit once the provider has alleged to the
State survey agency that it has addressed the deficiency identified in
the original complaint investigation. Complaint investigations that
find no deficiencies will not require any revisits and will therefore
not occasion any revisit fees.
8. Revenue Seeking--Government Responsible for Funding Survey Process
Comments: Several commenters felt that this proposed rule and the
assessment of revisit user fees was a revenue seeking mechanism, that
it was a way to fund and pay for the survey process. Many of these same
commenters felt that the obligation of the survey process and the
conducting of revisit surveys was that of the Federal government, and
or the State Health Departments. The government has mandated these
surveys and as such the quality assurance checks are its obligation.
One commenter felt that the Federal government's role is to raise these
funds, as been often done through Federal taxes, although not
advocating a Federal tax increase, it is through these like efforts the
commenter suggested that funds should be derived to pay for the survey
process.
Response: The revisit user fee is designed simply to pay for actual
costs of conducting revisits, on average, rather than as a revenue
generating instrument that might be unconnected with the government
activity for which the revisit user fee is assessed. In addition, the
revisit user fees offer the ancillary benefit of encouraging providers
and suppliers to commit to sustained compliance with Federal quality of
care requirements and ensure that quality lapses are remedied quickly.
9. Creating Positive Incentives
Comment: Although some commenters felt the revisit user fee was
punitive in nature and not proactive, several commenters did support
added incentives to increase patient and resident safety, quality of
care, and compliance to standards. A couple of commenters went on to
state that a positive incentive would serve to strengthen the
relationship between regulators and providers and would establish CMS
as a partner rather than an adversary of the long-term care community.
A few commenters indicated strong support of the Medicare survey
process as one method to assure only providers and suppliers that offer
high quality services participate in the Medicare program. One
commenter went as far as offering three goals for which the collected
user fees should be directed, which included improving consistency of
the survey process, ensuring complete, provider-specific training for
surveyors, and improving communication between State survey agencies
and the provider community on survey rules and expectations. This
commenter went on to state that fees derived for these survey program
improvements should not be used to merely supplant the normal funding
stream but dedicated to specific programs.
Response: The intent of the revisit user fee program is to recover
the costs associated with conducting follow-up visits for deficiencies
cited during initial certification, recertification, and substantiated
complaint surveys. Although the commenter offers three additional goals
for the collected revisit user fee, we believe that those admirable
goals go beyond Congress' intended purpose of the revisit user fee
program.
Part 424--Conditions for Medicare Payment
Subpart P--Requirements for Establishing and Maintaining Medicare
Billing Privileges
Section 424.535 Revocation of Enrollment and Billing Privileges in the
Medicare Program
We proposed to amend Sec. 424.535(a)(1) by adding a new sentence
to the criteria for which a provider or supplier may be determined not
in compliance and for which we may revoke enrollment and billing
privileges in the Medicare program. We proposed to add that the
provider or supplier may also be determined not to be in compliance if
it has failed to pay any user fees as assessed under part 488 of this
chapter. The paragraph will continue to read that all providers and
suppliers are granted an opportunity to correct the deficient
compliance requirement before a final determination to revoke billing
privileges occurs.
Comment: Some commenters tied in the discussion of revocation of
billing and the termination for nonpayment as proposed in Sec.
488.30(f) and Sec. 489.53(a)(16). One commenter felt that termination
for nonpayment within 30 days is power disproportionate to the offense
and is unrelated to quality of care and safety issues. Another
commenter felt that this provision is reason not to participate in
Medicare, or to care for Medicare patients.
Response: While we proposed that a provider or supplier may also be
determined not to be in compliance if a revisit user fee payment has
not been received within 30 calendar days after receipt of the notice
that payment is due, we also state at Sec. 424.535(a)(1) that all
providers and suppliers are granted an opportunity to correct the
deficient payment compliance before a final determination is made to
revoke billing privileges. We further note that a payment-due notice
from CMS is preceded by a survey or complaint investigation that has
found deficiencies, a correction period afforded to the provider or
supplier, a revisit to confirm compliance, then a later issuance of the
payment-due notice, followed by the formal 30-day advance notice to the
provider. As soon as a revisit occurs, each provider or supplier will
know that a revisit user fee will follow at a later date, will know the
amount of the fee due from the fee schedule published in this rule, and
will know that the payment will be due
[[Page 53632]]
within 30 calendar days. While the rule specifies that enforcement
action may occur if the bill has not been paid within 30 calendar days,
the total amount of planning time available to the provider or supplier
will have totaled much more than the 30 calendar day period before any
enforcement action may occur. Finally, the revocation of billing and
enrollment privileges is not an immediate action upon the failure of a
provider or supplier to remit the assessed revisit user fee. In this
final rule we therefore retain the time frames for which action will
occur regarding this process and retain the amended language to Sec.
424.535(a)(1) as final.
Part 488--Survey, Certification, and Enforcement
Subpart A--General Provisions
Section 488.30 Revisit User Fee for Revisit Surveys
We proposed a new Sec. 488.30 which set forth proposed regulations
that identifies the circumstances under which providers or suppliers be
assessed a user fee for revisit surveys connected with deficiencies
identified during surveys for initial certification, recertification,
or substantiated complaints. This proposed paragraph identifies the
assessment of fees, criteria for which the proposed fee schedule will
be based, and collection of fees.
Section 488.30(a)--Definitions
We proposed in Sec. 488.30(a) to define terms associated with this
paragraph. Those terms included: ``certification,'' ``complaint
surveys,'' ``substantiated complaint survey,'' ``provider of
services,'' ``provider,'' ``supplier,'' and ``revisit survey.'' Many of
the comments received for Sec. 488.30(a) dealt less with the wording
in the definitions and more with the survey and certification
activities and its process.
Certification (Initial or Recertification)
We proposed that ``certification'' (both initial and
recertification) would include those activities as defined in Sec.
488.1. ``Certification'' as currently defined in Sec. 488.1 is a
``recommendation made by the State survey agency on the compliance of
providers and suppliers with the conditions of participation,
requirements (SNFs and NFs), and conditions for coverage.''
Comment: One commenter proposed that home health agencies and
hospice facilities be removed from initial certifications since it can
take 2 or more years to get initial certifications. Another commenter
proposed that the revisit user fee should be expanded to include
initial surveys of ESRD facilities to allow more timely surveys that
now are delayed due to CMS budget, staff shortages, and other
priorities.
Response: Both commenters are referring to the issue of initial
certification surveys conducted for new providers or suppliers, rather
than the revisit surveys themselves.
While we appreciate the suggestion from one commenter that CMS
charge a fee for initial surveys so as to eliminate the current backlog
of unsurveyed and uncertified potential Medicare providers, we are
neither authorized by Congress nor prepared to charge such fees at this
time.
We also do not accept the suggestion from the other commenter that
home health agencies and hospices simply be exempt from initial
certification due to the survey backlog. We are not authorized to make
such exemption. We also believe an exemption would be inadvisable, as
it would permit those providers to begin to serve Medicare
beneficiaries without any assurance that they meet quality of care and
safety requirements. The proliferation of new home health and hospices
in a few States have also given rise to considerable concerns of fraud,
a concern that CMS is responding to through various anti-fraud
initiatives recently announced by the Secretary.
We do expect that the revisit user fee will indirectly help to
resolve the problem of surveying and certifying new providers. Revisit
costs represent a minority but still substantial portion of overall
survey and certification expenses. By defraying such costs through the
user fees, the States will then be in a better position to conduct tier
III and tier IV priority work, and will be able to conduct more initial
surveys than they have been able to conduct recently.
While we appreciate the comments, to adhere to the Congress intent
within the Continuing Resolution, we will not assess a fee for initial
certification, nor at this time can we remove providers or suppliers
based on when initial certifications are conducted. We will retain the
proposed definition of ``certification'' as final.
``Complaint Surveys''
We proposed that complaint surveys are those surveys conducted on
the basis of a ``substantial allegation of noncompliance,'' as defined
in Sec. 488.1. The term ``substantial allegation of noncompliance''
means:
A complaint from any of a variety of sources (including
complaints submitted in person, by telephone, through written
correspondence, or in newspaper or magazine articles) that if
substantiated, would affect the health and safety of patients and
raises doubts as to a provider's or supplier's noncompliance with
any Medicare condition. (42 CFR Sec. 488.1)
We further noted that the Continuing Resolution included the term
``substantiated complaints surveys.'' We proposed that ``substantiated
complaint survey'' means a complaint survey that results in the proof
or finding of noncompliance at the time of the survey, a finding that
noncompliance was proven to exist, but was corrected prior to the
survey, and includes any deficiency that is cited during a complaint
survey, whether or not the deficiency was the original subject of the
substantial allegation of noncompliance.
We proposed that a user fee would be assessed for revisit surveys
conducted to evaluate the extent to which deficiencies identified
during a substantiated complaint survey have been corrected.
Comment: Commenters requested clarification on the term
``substantial allegation of noncompliance,'' and felt that the
definition as a basis for the revisit fee is vague and open-ended.
Response: CMS proposed the definition for ``complaint surveys'' to
mean those surveys conducted on the basis of a substantial allegation
of noncompliance, as defined in Sec. 488.1. ``Substantial allegation
of noncompliance'' has been the term used in current survey,
certification, and enforcement procedures and as such we intended to
maintain a level of consistency by utilizing this definition as a means
to define ``complaint surveys.'' It is this process that generates the
action for which an investigation into the complaint should occur. It
is the substantiation of this complaint survey that will determine if a
revisit survey should be conducted and as a result a revisit user fee
should be assessed. As we provided in the discussion of the proposed
rule ``substantiated complaint survey'' means a complaint survey that
results in (1) the proof or finding of noncompliance at the time of the
survey, (2) a finding that noncompliance was proven to exist, but was
corrected prior to the survey, and (3) includes any deficiency that is
cited during a complaint survey, whether or not the deficiency was the
original subject of the substantial allegation of noncompliance. If any
of these 3 situations are determined and a revisit is required as a
result of the situation, then a revisit user fee will be assessed. It
will not simply be based on whether the complaint was substantiated. A
complaint may be substantiated without
[[Page 53633]]
being determined to be non-compliant with the regulations. The
substantiation of a complaint is a separate issue from the
determination of compliance with the regulations and thus the
triggering of a revisit user fee.
Comment: One commenter contends that accepting complaints from a
variety of sources is overly broad and permits the process to go
forward at great length. Another commenter felt that there is nothing
to prevent disgruntled employees from submitting complaints
anonymously, especially once they learn that the user fee will punish
the facility. Commenters felt that this provides incentive for
surveyors to substantiate the compliant that triggered the revisit or
substantiate another deficiency.
Response: We do not expect that either the quantity of complaints
received or the source of the complaints will affect revisit user fees
to any measurable extent. The revisit user fee does not apply to any
complaint investigation. Only complaints which have been substantiated
as showing non-compliance with Federal requirements will result in
citation of a deficiency. Only those deficiencies that require a
revisit survey will then trigger a revisit user fee. When multiple
complaints are received near the same point in time, State survey
agencies typically bundle those together in one complaint
investigation, this investigation is followed by a revisit survey only
if one or more of the complaints is substantiated and the agency finds
noncompliance to such an extent that a revisit is called for according
to CMS policy. Finally, the volume of complaints reaching CMS are to
some extent affected by the extent that the provider or supplier has an
effective system of inviting complaints internally, and responding to
complaints effectively such that beneficiaries or their families feel
that there is less need to file complaints with CMS or any external
party. We believe that beneficiary complaints represent a very
important source of feedback for providers, suppliers, CMS and States.
We hope such feedback can be effectively used by us and others to
identify areas of health care that merit serious attention.
Comment: One commenter disagreed that a ``substantiated complaint
survey'' can cite any deficiency regardless of whether that deficiency
was the original subject of the complaint. Two commenters raised
concerns that a revisit user fee will be imposed even in cases where a
``substantiated complaint'' is corrected prior to the survey or that
CMS would require a revisit user fee in this instance and this would
discourage a facility's internal quality assurance. A commenter raised
the questions as to whether a substantiated complaint included
condition and standard levels or just condition level. This commenter
proposes that it just include condition level since those levels result
in non-certification or decertification.
Response: CMS published condition of participation, condition for
coverage and other regulatory requirements typically take the form of
specific standards, with multiple standards related to a common topic
comprising a broader ``condition.'' Revisit surveys are almost always
required for condition-level deficiencies and are also often required
for standard-level deficiencies, depending on the extent and
seriousness of the noncompliance identified. As we provided in the
discussion of the proposed rule, ``substantiated complaint survey''
means a complaint survey that results in (1) the proof or finding of
noncompliance at the time of the survey, (2) a finding that
noncompliance was proven to exist, but was corrected prior to the
survey, and (3) includes any deficiency that is cited during a
complaint survey, whether or not the deficiency was the original
subject of the substantial allegation of noncompliance. If any of these
3 situations are determined and a revisit is required as a result of
the situation then a revisit user fee is assessed.
Although we disagree in part with the commenter who indicated that
any deficiency can not be cited during a complaint survey, we reiterate
and clarify that under our current policy for conducting complaint
surveys, we do require that if a State surveyor in the course of
conducting the complaint survey observes a situation that warrants
further investigation, that the State must seek input from the CMS
regional office to request permission to further pursue this additional
situation. See U.S. Centers for Medicare & Medicaid Services. State
Operations Manual, ``Complaint Procedures.'' ONLINE. 2006. CMS.
Available: https://www.cms.hhs.gov/manuals/downloads/som107c05.pdf
(``SOM-Complaint'').
With regard to the two commenters'' concern that a finding that
noncompliance was proven to exist, but was corrected prior to the
survey, this situation alone would not trigger a revisit user fee. In
addition, because a substantiated complaint survey can include the
above criteria we do not believe at this time that we should make a
distinction between a condition level deficiency and a standard level
deficiency. As a continued part of the survey and certification process
a complaint may be substantiated without being determined to be non-
compliant with the regulations. The substantiation of a complaint is a
separate issue from the determination of compliance with the
regulations and thus the triggering of a revisit user fee.
We appreciate the comments, however to adhere to consistency across
current survey and certification policy, we will retain the definition
of ``complaint surveys'' to mean those surveys conducted as the basis
of a substantial allegation of noncompliance, as defined in Sec. 488.1
as final.
``Provider of Services, Provider, or Supplier''
We proposed to retain the terms ``provider of services,''
``provider,'' or ``supplier'' as defined in Sec. 488.1. We proposed
that all ``provider of services,'' ``providers,'' or ``suppliers,'' as
defined in Sec. 488.1, will be subject to user fees, unless otherwise
exempted through the final rule. We proposed that a ``provider of
services'' or ``provider'' that may be assessed a user fee, as it
applies in this proposed rule, includes a hospital, critical access
hospital, skilled nursing facility, dually-participating nursing
facility (``SNF/NF''), home health agency (``HHA''), and hospice.
Transplant centers would also be subject to user fees and have been
defined in Sec. 482.70 of this chapter. We proposed that ``providers
of services'' or ``providers'' that will not be assessed a revisit user
fee as defined in the proposed rule to be comprehensive outpatient
rehabilitation facilities, transplant centers, and providers of
outpatient physical therapy or speech pathology services. These
providers are excluded from this rule because they are not subject to a
routine survey process as are other service providers. We stated that
Medicaid-only ``providers of services'' or ``providers'' will not be
assessed a user fee.
We proposed a ``supplier'' that may be assessed a user fee, as it
applies in the proposed rule includes an end-stage renal disease
center, a rural health clinic (``RHC''), and an ambulatory surgical
center (``ASC''). ASCs must have an agreement with CMS to participate
in Medicare and must meet conditions for coverage as defined in Part
416 of this chapter.
``Suppliers'' that would not be assessed a user fee under the
proposed rule are independent laboratories, portable x-ray centers,
physical therapists in independent practice, Federally Qualified Health
Centers (FQHCs), and chiropractors. These
[[Page 53634]]
suppliers are excluded because they are not subject to a routine survey
process as are other suppliers. We stated that Medicaid-only
``suppliers'' will not be assessed a user fee.
The proposed rule would not interfere with user fees associated
with clinical laboratories as established by the Congress, which passed
the Clinical Laboratory Improvement Amendments (CLIA) in 1988 and
established that outpatient clinical laboratory services are paid based
on a fee schedule in accordance with section 1833(h) of the Act.
We received several comments regarding our definition of ``provider
of services,'' ``provider,'' or ``supplier'' and we have included them
below.
Comment: One commenter indicated that Chiropractors status among
the Allied Health Care professions remains in dispute, this commenter
contends that Chiropractors should be excluded from any Medicare
provider list.
Response: Our current regulations found in Sec. 488.1 include
Chiropractors as identified as a supplier. This particular definition
section also has extensive implications in various parts of the
Medicare and Medicaid program and although we appreciate the
commenter's concern, we do not propose to remove chiropractors from the
definition of supplier. We do reiterate that Chiropractors are not
subject to the revisit user fees.
Comment: One commenter believed that the implementation of this
rule should not coincide with the publication of the final rule for
ESRD conditions of coverage. This commenter felt that revisits and
assignment of fees could very well be excessive during the ``learning
curve'' of the new regulation; if CMS has such discretion the commenter
suggests that this final rule should state that revisit user fees for
ESRD facilities will not apply for the first 12 months of
implementation of new conditions for coverage.
Response: The commenter is referring to the future publication of
the final CMS rule revising the Conditions for Coverage for end stage
renal disease facilities (ESRD). New rules or substantial revisions of
new rules are typically promulgated with future effective dates.
Considerable educational communications usually precede the effective
date, during which providers or suppliers have an opportunity to become
familiar with the rule and make necessary changes before the survey
process holds them accountable. Currently, ESRD surveys are conducted
about once every three to five years. We therefore believe that there
will be reasonable opportunities for providers to adjust to the new
rules before they are affected by surveys and the later revisits that
might follow some surveys. Finally, although we appreciate the
commenter's suggestion, we do not have the discretion at this time to
exclude ESRD facilities from this final rule. ESRD facilities and
revisits costs were included within the President's budget projections
and mandated by the Congress.
Comment: One commenter expressed concern that religious nonmedical
health care institutions (RHNCIs) would be subject to the revisit user
fees.
Response: We appreciate the comment received. We inadvertently did
not include religious nonmedical health care institutions (RHNCIs) in
the definitions. RHNCIs should have been included, as they are subject
to the survey and certification process. To adhere to the intent of the
Congress and maintain consistency of definitions across Medicare and
Medicaid programs, we will retain the definitions as proposed with the
exception that we will include RHNCIs in the definition. However, in
the fee schedule in this final rule we exempt them from the user fee
program due to the very small number of such facilities and their
relatively unusual nature. Any change to the exemption status would be
preceded by publication of a Federal Register notice. The final
definition of ``provider of services,'' ``provider,'' or ``supplier''
will read ``Provider of services, provider, or supplier'' as defined in
Sec. 488.1, and ambulatory surgical centers, transplant centers, and
religious nonmedical health care institutions subject to Sec. 416.2,
Sec. 482.70, and Sec. 403.702 of this chapter, respectively, will be
subject to user fees unless otherwise exempted.
``Revisit Survey''
In the Proposed Rule CMS defined the term ``revisit survey'' to
mean a survey performed with respect to a provider or supplier cited
for deficiencies during an initial certification, recertification, or
substantiated complaint survey and which is designed to evaluate the
extent to which previously cited deficiencies have been corrected. We
further proposed that for purpose of this rule revisit surveys include
both offsite and onsite. We also reiterated that regulations
established in Sec. 488.26 of this same part provided regulatory
requirements for conditions of participation, conditions for coverage,
or other regulatory requirements. Specifically Sec. 488.26 of this
part states that the compliance determination is made by the State
survey agency and includes a survey process that assesses compliance
with Federal health, safety, and quality standards.
We received only a few comments regarding the term ``revisit
surveys'' and received the majority of comments under this section
reflecting commenters concern regarding the survey process and the
manner in which revisit user fees will be assessed.
1. ``Revisit Survey'' Term
Comment: Several commenters requested that we redefine the term
``revisit survey'' so that the definition does not include desk reviews
or offsite surveys, that the offsite (desk) reviews be defined, that
fees only be imposed if the survey is done in accordance with already
established policies per provider type, that the definition include
criteria about when onsite revisits are required, and that we limit the
fees to ``onsite revisit surveys.''
Response: We included offsite revisit surveys (desk reviews)
because we wished to retain the option of the offsite revisit surveys
where warranted, since the cost to providers and suppliers under the
revisit fee program will be substantially less than for onsite revisit
surveys. The function of onsite and offsite (desk review) revisit
surveys is the same. We interpret both types to constitute revisits
within the meaning intended by Congress. The Continuing Resolution
requires fees to be assessed that are necessary to cover the costs
incurred for conducting revisit surveys on health care facilities cited
for deficiencies found during initial certification, recertification,
or substantiated complaint surveys. As we observed, we do not interpret
this to mean onsite revisit surveys only. Within the current survey
process itself there are distinctions made for when an onsite or
offsite revisit survey should occur and distinctions are made by
provider and supplier type. See U.S. Centers for Medicare & Medicaid
Services. State Operations Manual, ``Survey and Enforcement Process for
Skilled Nursing Facilities and Nursing Facilities,'' Online. 2004. CMS.
Available: https://www.cms.hhs.gov/manuals/downloads/som107c07.pdf, and
also ``Additional Program Activities,'' Online. 2007. CMS. Available:
https://www.cms.hhs.gov/manuals/downloads/som107c03.pdf.
We disagree that revisit surveys should only be those that were
conducted onsite, as there are situations in which offsite reviews are
required to verify that the contents of the plan of correction or the
corrective action took place. We do, however, agree that a review of a
plan of correction that does not require verification beyond the plan
[[Page 53635]]
of correction document itself would not constitute an offsite revisit
survey (as defined here), and thus the provider or supplier would not
be assessed a revisit user fee in such a circumstance. A provider or
supplier will be assessed a revisit user fee for an offsite revisit
survey if the deficiency or deficiencies cited are of a nature that the
content of the plan of correction and the statements made by the
provider or supplier require verification and offsite follow-up to
ensure that the corrective action has brought the provider back into
compliance with federal requirements.
We appreciate the comments received; however on the term ``revisit
survey,'' based on our discussion we will retain the proposed
definition of ``revisit survey'' as final.
2. Survey Process
CMS discussed the current revisit policy and survey and
certification process already established for all providers and
suppliers. We identified current policy for skilled nursing facilities
and dually-participating nursing facilities, performed at the
discretion of CMS or the State. This revisit policy indicates
circumstances for which onsite revisits must occur for certifying
compliance and circumstances when onsite revisits are discretionary.
Likewise, CMS generally permits only two revisits for hospitals, home
health agencies, hospices, ambulatory surgical centers, rural health
clinics, and end-stage renal disease centers. Of these two revisits
permitted by CMS, one revisit should occur within 45 calendar days of
the initial certification, recertification, or substantiated complaint
survey, and one revisit subject to CMS approval, between the 46th and
90th calendar days. See 72 FR 35676 (discussing revisit policy,
including discussion on revisits related to Immediate Jeopardy).
2A. Survey Process: Skilled Nursing Facilities and Dually-Participating
Nursing Facilities
Comment: Several commenters contended that the survey process is
inconsistent and subjective, and proposed that the revisit user fees be
postponed until these process issues are resolved. Another commenter
felt that revisit user fees represent punishment, especially when
deficiencies are erroneously cited. Two commenters requested assurances
that only legitimate deficiencies will be cited, that unnecessary
revisits will not be conducted, and that revisits will not be conducted
solely for the purpose of collecting user fees. One commenter felt that
the proposed rule will complicate the subjectivity and variability that
will always be part of the survey process. Another commenter indicated
that the survey process is broken and subjective, and as such, fees for
revisits would be unfair until those problems are resolved.
Response: CMS continuously works with States to ensure that surveys
are applied as consistently as possible. CMS also operates a national
internal consistency program in which validation surveys are conducted
by Federal surveyors to promote optimum consistency. For example,
Federal surveyors conduct validation surveys on a 5% sample of nursing
home surveys to check the accuracy and adequacy of State surveys. CMS
then works with the States to adjust for any significant disparities.
The issue of consistency is also monitored as part of CMS's review of
State performance. Because no system is perfect, nursing homes have an
opportunity to request review of any cited deficiency through a
structured informal dispute resolution process. CMS takes the issue of
consistency seriously, and we continue to develop additional methods to
analyze and address consistency issues, one example is the new Quality
Indicator Survey (QIS) process that has been pilot-tested in five
States. The QIS process utilizes customized software and is designed as
a staged process for use by surveyors to systematically review
requirements and objectively investigate all triggered regulatory areas
in an effort to meet several objectives, one of which is to improve
consistency and accuracy of quality of care and quality of life problem
identification. We believe that the revisit user fee will help address
those limitations and make more feasible a number of additional
consistency improvements that are underway.
Comment: One commenter feared that there are no constraints to
prevent a surveyor from citing an already corrected problem in order to
trigger a revisit. One commenter believed that the survey process is
already stressful for facility staff and this will only be made worse
for employees who fear any mistake could trigger a revisit and its
associated fee.
Response: If a problem has already been corrected at the time of a
standard survey or complaint investigation, the survey itself can
confirm that the correction has brought the provider or supplier back
into compliance with federal requirements and the surveyor would
document such a determination. In such a case no revisit would be
required unless the correction failed to assure compliance. We
appreciate that the survey process can be inherently stressful for
employees. We do not believe, however, that the amount of the revisit
fee is so much as to add measurably to the pre-existing stress level
for employees. The cost of a revisit fee can be compared favorably to
the larger cost to beneficiaries from poor quality of care, or to the
larger financial cost to providers from serious non-compliance with
federal requirements, such as civil monetary penalties or termination
of the provider agreement. Only in the case of multiple revisits would
we expect the cumulative cost of revisits fees to become a significant
expense for a particular provider. A large number of revisits would
occur when there is a persistent pattern of poor quality and documented
inability of a provider or supplier to sustain compliance with federal
requirements. Such providers face more serious consequences than
revisit user fees. We believe that the plain language of the Continuing
Resolution mandates that a fee be collected whenever a revisit occurs
as a result of a deficiency found during initial certification,
recertification, or substantiated complaint surveys. Documentation
requirements supporting deficiency citations are not being diminished,
eliminated or otherwise changed by this proposed rule to create the
scenario raised by the commenter.
Comment: One commenter proposed that onsite revisits be
discretionary for single ``G'' level deficiencies. Another commenter
indicated that it is unclear what level deficiency would necessitate a
revisit. A few commenters believed that oversight of correction of some
deficiencies could be done offsite and requested clarification about
when onsite revisits are required.
Response: Our current policy requires onsite revisits for condition
level citations. The current policy governing revisit surveys is
described in our online state operations manual. We will, however,
consider policy issues raised by several of the commenters for future
reconsideration. Some professional discretion on the part of State
survey agencies will always be required. CMS provides review and
oversight of State survey agencies through the CMS regional offices.
Our internal quality assurance system provides for regional office up-
front input or subsequent review when there is concern regarding
whether the revisit survey should be conducted onsite or offsite.
However we have always maintained that a condition level citation
requires an onsite revisit survey. ``G'' level deficiencies in nursing
homes are serious and are cited only when one or more nursing home
[[Page 53636]]
residents have been harmed. We will continue to conduct revisits in
such circumstances.
2B. Survey Process: Hospitals, Home Health Agencies, Hospices,
Ambulatory Surgical Centers, Rural Health Clinics, and End-Stage Renal
Disease Centers
Comment: One commenter felt that although survey teams work off the
same worksheets, there is variation in how different survey teams
assess similar situations. Therefore, the commenter felt that requiring
a ``revisit'' fee for all resurveys (either onsite or offsite) will
increase the number of times that home health agencies will contest the
survey findings, which then they may enter into an informal dispute
resolution process not only to avoid the revisit fee but also to
respond to the issue of survey variation.
Response: CMS continuously works with States to ensure that surveys
are as consistently applied as possible. CMS also operates a national
internal consistency program in which validation surveys are conducted
by Federal surveyors to promote optimum consistency. It is possible
that the revisit user fees may have the ancillary effect of increasing
the extent to which providers or suppliers dispute the findings of
surveys or complaint investigations. We believe this may occur whether
the revisits are offsite or onsite. We will monitor the effect of the
revisit fees to determine if any future adjustments are advisable.
Comment: One commenter requested clarification on whether user fees
will be imposed on accredited providers or suppliers for a revisit
following a sample validation survey.
Response: We will not charge a fee for a validation survey of a
provider or supplier that has been duly accredited by a CMS-approved
accrediting organization and deemed to meet Medicare requirements.
While we believe that a revisit fee pursuant to a validation survey has
basis, it is absent in the language of the Continuing Resolution. We
would view this as similar to a revisit survey conducted for a non-
accredited provider; we did not however specify such a charge in the
proposed rule. We will therefore not charge a revisit user fee in this
final rule for a revisit that follows a validation survey, provided
that the deemed status of the provider or supplier has not been removed
by CMS. However, any survey, including a validation survey, that finds
noncompliance with a Condition (compared to just a Standard), typically
requires removal of deemed status and a full survey of a provider. When
an accredited facility is found not to be in substantial compliance
with the Medicare Conditions of Participation or Conditions for
Coverage, it must remain under the jurisdiction of the State Survey
Agency until the State Survey Agency verifies through revisits that the
facility has corrected its deficiencies and demonstrated substantial
compliance. We believe in this case, the removal of deemed status that
initiated with a validation survey, that then remains under the
jurisdiction of the State survey agency is equivalent to any other
provider or supplier seeking recertification. In this case a provider
or supplier cited for a deficiency during a recertification survey that
requires a revisit survey would be assessed a revisit user fee.
Comment: One commenter requested clarification as to whether a full
survey following a substantiated complaint survey in a deemed provider
or supplier is a revisit as defined in proposed Sec. 488.30(a).
Response: A full survey that is conducted pursuant to a complaint
investigation of an accredited facility that has fou